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Abstract
Vector-transmitted parasitic infections are a global health problem. Diseases such
as malaria are a major health threat and economic burden for developing coun-
tries. In Sub-Saharan Africa malaria causing Plasmodium parasites may evoke life
threatening complications, which mainly affect children under the age of five years.
Pathogenesis of cerebral malaria is a multifactorial complex process that involves
inflammatory mediators such as effector T cells and IFN-γ. Time, origin and cel-
lular and molecular factors involved in early immune responses priming effector
T cells responsible for the pathogenesis of cerebral malaria have been less investi-
gated. In our study we were able to determine the presence of parasite specific cy-
totoxic T cells in spleen and brain during Plasmodium berghei infection. This enabled
us to analyse cellular interactions involved in the priming of T cells directed against
the parasite. The place of essential T cell priming during Plasmodium infections was
determined in splenectomised mice, in which effector responses were reduced and
experimental cerebral malaria (ECM) pathology was absent. Depletion of antigen-
presenting cells, involved in maintaining the organized splenic structure, abro-
gated T cell priming and resulted in the loss of effector responses. Without either
macrophages, DCs or B cells lytic activity and IFN-γ production by parasite-specific
T cells was diminished and in the absence of effector responses ECM progression
was suppressed. In detail, we provide evidence that macrophages, B cells and den-
dritic cells, as well as CD4+ T cells together with TLR-9 and IL-12 signalling com-
prise complex interactions affecting T cell generation during blood stage malaria
leading to neuropathology.
Taken together our study suggests, that early immune responses during P. berghei
infection are generated in the spleen and that distinct cells and cytokines drive gen-
eration of parasite-specific T cells leading to subsequent pathology.
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Abstrakt
Durch Vektoren übertragene Parasiteninfektionen stellen weltweit eine große Her-
ausforderung dar. Krankheiten, wie z.B. Malaria bergen große gesundheitliche,
aber auch ökonomische Risiken. Malaria, ausgelöst durch eine Plasmodium-
Infektion, ist eine schwerwiegende Krankheit mit zum Teil lebensgefährlichen Kom-
plikationen, die insbesondere Kinder unter fünf Jahren betreffen. Die Pathogenese
von zerebraler Malaria ist ein multifaktorieller und komplexer Entzündungs-
prozess, bei dem Effektor T-Zellen und IFN-γ eine wichtige Rolle spielen. Obwohl
T-Zellen stark in die Entwicklung zerebraler Malaria involviert sind, ist über Ur-
sprung, zeitliche Abfolge und zelluläre und molekulare Prozesse der frühen Immu-
nantwort, die für die Aktivierung von Effektor T-Zellen verantwortlich sind, bisher
wenig bekannt. Wir konnten die Existenz von Parasiten-spezifischen zytotoxis-
chen T-zellen in der Milz und im Gehirn während einer Plasmodium berghei ANKA
Infektion in einem Mausmodell nachweisen. Das Entfernen der Milz ging mit
einem reduziertem Risiko der zerebrale Malaria und einer verminderten Entzün-
dungsreaktion einher. Dies zeigte, dass Effektor T-Zellen in der Milz generiert wer-
den. Durch die Depletion Antigen-präsentierender Zellen, welche strukturgebend
für die Milzarchitektur sind, wurde die Generierung und Aktivierung von Effek-
tor T-Zellen verhindert und inflammatorische Reaktionen unterbunden. In Abwe-
senheit von Makrophagen, dendritischen Zellen, oder B-Zellen war die zytotoxis-
che Aktivität und die INF-γ Antwort reduziert und neuropathologische Symptome
blieben aus. Dies deutet darauf hin, dass komplexe Interaktionen von Makropha-
gen, B-Zellen, und dendritische Zellen, sowie CD4+ T Helfer Zellen zusammen
mit TLR-9 und IL-12 Signalwegen, die T-Zell-Generierung in einer Plasmodium-
Infektion und somit die Pathogenese von zerebraler Malaria stark beeinflussen.
Zusammengefasst liefert dieses Projekt Hinweise dafür, dass die frühe Immunant-
wort gegen den Parasiten in der Milz hervorgerufen wird, wobei spezifisch Immun-
zellen und Zytokine an der Bildung von Effektor T-Zellen beteiligt sind, welche
wiederum zu der Entstehung von neurologischen Schäden führen.
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ICAM intercellular adhesion molecule; CD54
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1 Introduction
1 Introduction
Developing countries, especially in Sub-Saharan Africa, have to cope with diseases
like HIV, tuberculosis and malaria. In 2008 around 250 million cases and almost
a million deaths (WHO, 2010) were caused by malaria, a disease induced by infec-
tion with the vector-transmitted parasite Plasmodium spp.. Investigations of mecha-
nisms involved in protective and detrimental immune responses against the proto-
zoan parasite remain far from being unveiled. This study aimed to elucidate early
parasite-specific immune responses in the spleen involved in the pathogenesis of
cerebral malaria.
1.1 General concepts about malaria
1.1.1 Epidemiology
Five species of the protozoan parasite from the genus Plasmodium are relevant for
humans. Infection with Plasmodium vivax, P. ovale, P. malariae, P. falciparum and P.
knowlesi can cause disease, with complications ranging from benign to very severe.
Usually, these parasites are well adapted to their host species. The primate parasite
P. knowlesi, however, is also infectious for humans and pathology is comparable to
the other infective strains. Widely distributed and adopted to various conditions
Plasmodium transmitting Anopheles mosquitoes render half the world population in
108 countries and territories at risk of infection. In tropical regions, especially in
sub-Saharan Africa, Plasmodium falciparum is the major cause of severe debilitating
illness that accounts for an estimated 1 million deaths worldwide and is responsible
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for 20% of infant mortality in Africa. Besides health issues, malaria has a high socio-
economic burden for developing countries and despite being curable, in areas of
poor infrastructure access to early treatment is difficult (WHO, 2010).
1.1.2 Life cycle
Infected female Anopheles mosquitoes transmit Plasmodium-sporozoites to the host
during the blood meal. Sporozoites migrate out of the salivary gland and are in-
jected into the host. Sporozoites are either directly injected into the blood stream
or into the skin from where they migrate into the blood vessels to enter blood cir-
culation (Yamauchi et al., 2007). With the blood circulation some sporozoites reach
the liver where they pass through several tissue cells inducing the first immune
responses to the parasite before they invade hepatocytes. Within the hepatocytes
sporozoites reside in a parasitophorous vacuole, in which they reproduce by mul-
tiple fission generating thousands of daughter parasites. This developmental stage
is asymptomatic and lasts 6-15 days. When the division is completed, schizonts
release single merozoites into the blood stream. New erythrocytes are quickly in-
vaded, where daughter parasites multiply through schizogonie very fast. After 48
to 72 hours parasitized erythrocytes burst and released merozoites that immedi-
ately infect new erythrocytes. In parallel, some merozoites differentiate into male
and female gametocytes, which complete the life cycle when taken up by another
mosquito (Bogitsh et al., 2005).
1.1.3 Clinical disease
Clinical pathology of malaria arises from the blood stage of infection. Infected in-
dividuals may experience regularly reoccurring fever peaks. This is caused by the
synchronized parasite discharge from infected erythrocytes, which is accompanied
by the release of pyrogenic mediators. Differing growth rates of human plasmodial
parasites lead to a species-specific characteristic periodicity. Tertian malaria origi-
nating from P. vivax and P. ovale causes febrile episodes every 48 hours. After in-
fection with P. malariae (quartan malaria) patients experience fever bursts every 72
hours. Erythrocyte release from P. falciparum is less synchronized and does not
2
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Figure 1.1: Life cycle of Plasmodium spp.
Female Anopheles mosquitoes transfer sporozoites during a blood meal to the vertebrate
host. After inoculation parasites travel to the liver where they invade hepatocytes.
Intracellular division takes place within hepatocytes and after 2-7 days parasites are
released into the blood stream from ruptured cells. Free merozoites readily infect ery-
throcytes in which asexual reproduction takes place followed by the release of daughter
cells and invasion of fresh cells. In infected erythrocytes some parasites develop into
male and female gametocytes, which then can be taken up by a blood feeding vector
and the cycle starts over (adapted from Miller et al. (2002)).
show a stringent pattern in fever episodes, which may occur in 48 - 72 hour inter-
vals (Bogitsh et al., 2005). 80% of the worlds malaria cases are caused by Plasmodium
falciparum, which is also responsible for severest complications increasing the risk
of death. Two characteristic traits of this species are associated with pathology. For
one P. falciparum has the ability to infect any erythrocyte without regard to age or in-
fectious status, leading to higher parasite burdens. Increased destruction of infected
and uninfected erythrocytes can cause severe malaria anaemia (SMA). Involvement
of the immune system causing anemia has been proposed but detailed mechanisms
remain to be described (Schofield and Grau, 2005). Secondly, expression of parasite
3
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cell-surface proteins on host erythrocytes alter adhesion properties and infected
erythrocytes thereby escape immune-recognition in the spleen through tissue se-
questration. Site-specific adhesion of parasitized red blood cells, concomitantly
with host inflammatory reactions contribute to drastic disease progression. Cere-
bral malaria is defined by the presence of unarousable coma, asexual forms of P.
falciparum in blood and exclusion of other causes of encephalopathy (Newton and
Warrell, 1998). Exact mechanisms leading to neuropathogenesis are still not fully
understood. In recent years perception of cerebral malaria pathogenesis has shifted
from tissue sequestration being the sole cause towards a more global notion, in
which sequestration, inflammation and dysregulated hemostasis are considered to
be critically involved in disease progression (van der Heyde et al., 2006; Clark and
Alleva, 2009; Combes et al., 2010). Despite immense research efforts and increasing
knowledge, the multifactorial cerebral malaria syndrome is far from being under-
stood let alone from being eradicated. Challenges in treating CM-patients arise i)
early diagnosis of CM is difficult as reliable predictive markers are scarce (Martins
et al., 2009), symptoms are rarely distinct and are sometimes misdiagnosed (Mil-
ner, 2010), ii) access to health care and medical treatment in countries with high
CM incidences is limited (WHO, 2010).
1.2 Immunology of malaria
Despite having strictly defined clinical criteria, cerebral malaria is a heterogeneous
condition with several factors contributing to pathogenesis. Although critically de-
bated, excessive host immune responses are now considered to be at least partially
responsible for disease progression. Clinical studies examining parasite-host in-
teractions before and during neuropathogenesis are strongly restricted by ethical
constraints and remain descriptive.
1.2.1 Rodent model of cerebral malaria
Human studies focusing on local immune responses in specific organs after P. fal-
ciparum infection are, for obvious ethical reasons, limited to post-mortem examina-
4
1 Introduction
tions. However, important information regarding host-pathogen interactions and
immunological responses in time and placed tissue tropism can be examined in an
experimental murine model of cerebral malaria. Plasmodium berghei infection in sus-
ceptible strains (Rest, 1982; Curfs et al., 1993b) induces pathology in mice, which is
comparable to pathology seen in humans. Although the similarities of the murine
model of experimental cerebral malaria (ECM) continue to be debated (de Souza
et al., 2010; White et al., 2010). The absence of erythrocyte sequestration but pres-
ence of leukocytes and platelets in ECM positive mice as well as differences in in-
flammatory responses against the parasite are some of the criticized differences to
human cerebral malaria. Nevertheless, sequestration in brain capillaries being the
major factor causing neuropathology seems to be overrated, as some tissue samples
from deceased cerebral malaria patients were devoid of parasite and erythrocyte se-
questration (Clark et al., 2003). Several reviews elucidated and discussed the factors
involved and sequence of events leading to Plasmodium induced neuropathogene-
sis (Milner, 2010; Clark and Alleva, 2009; van der Heyde et al., 2006) coming to the
conclusion that sequestration, inflammation or dysregulated homeostasis can all be
associated with pathology. In patients, analysis of inflammatory responses during
Plasmodium infection are limited to peripheral blood, and in rare cases liquor and
post-mortem tissue samples. Thus experimental models, despite incompletely re-
sembling human disease, give the possibility to match age, genetic background and
experimental readouts regarding immune responses at specific time points in spe-
cific organs. Hence, giving valuable insights into the complex interactions of host
immunity and parasite infection.
1.2.2 The spleen
The spleen as secondary lymphoid organ is involved in clearing blood borne infec-
tions and generation of adaptive immune responses (Engwerda et al., 2005). Highly
specialized compartments constitute the splenic architecture, in
which very efficient innate and adaptive immune responses can be mounted
(Mebius and Kraal, 2005). Circulating blood flows through arterioles into the mar-
ginal sinus and red pulp. The marginal sinus, a part of the marginal zone (MZ) di-
vides the red and the white pulp regions. Specialized macrophage populations, the
5
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marginal metallophillic macrophages (MMMs) and marginal zone macrophages
(MZMs) together with B cells and trafficking dendritic cells (DCs) and T cells make
up the MZ. Marginal zone macrophages are highly efficient in removing blood
pathogens and pathogen particles. Metallophillic macrophages, in addition to
phagocytic properties, have recently been shown to transfer processed antigen to
dendritic cells which prime effector T cells through cross-presentation (Backer et al.,
2010). The marginal zone directs antigen-presenting cells (APCs) to the white pulp,
which consists of the B cell follicles and the periarteriolar lymphoid sheath (PALS).
In the PALS trafficking dendritic cells come into contact with resident T cells, which
are readily primed by antigen recognition.
During Plasmodium infection the spleen clears infected erythrocytes, and parasite
particles. This property has been linked to increased incidence of splenomegaly
and reduced parasite burden, but also to severe malaria anaemia (Buffet et al.,
2009). Splenectomised malaria patients have been described to have increased par-
asite burden (Chotivanich et al., 2002; Looareesuwan et al., 1993). In a murine ECM
model, splenectomy reduced the generation of cerebral pathology (Hermsen et al.,
1998; Eling, 1980). Moreover, structural changes of the spleen have been observed
in lethal cases of P. falciparum infection. The white pulp especially shows increased
disorganisation with B cells absent from the marginal zone, unsegregated T cell ar-
eas and T cells diffusely scattered in the white pulp (Urban et al., 2005). Immune
responses in the spleen are on the one hand required to control parasitemia and
generate anti-parasitic responses. On the other hand, early interactions between
parasite and immune cells can lead to effector cell generation potentially harmful
for the host.
1.2.3 Antigen-presentign cells (APCs)
Blood circulation transports pathogens and pathogen particles into the spleen,
where cells of the innate immune system are the first to encounter micro-organisms.
After phagocytosis, antigens are processed and peptides presented either in a major
histocompatibility complex (MHC) class I or MHC class II context. T cells recognize
peptide-MHC complexes via the T cell receptor and this interaction, together with
co-stimulatory signals, leads to priming of T cells.
6
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Macrophages
Macrophages, situated in the spleen at the interface where blood passes through,
are the first cells to come across pathogens. Receptor recognition of pathogen-
surface molecules induces phagocytosis and intracellular destruction in macro-
phage lysosomes. Elimination of micro-organisms is followed by processing anti-
genic peptides, although not very efficient, these can be presented to activated T
cells to induce effector function. Activated macrophages secrete a wide range of
inflammatory mediators, including chemokines and cytokines, which participate
in initiation of adaptive immune responses (Janeway et al., 2001). Macrophages
have been implicated in the pathogenesis of cerebral malaria in humans (Baratin
et al., 2005) and murine experimental models of CM (Pais and Chatterjee, 2005;
Couper et al., 2010). Parasites are cleared mainly by monocytes/macrophages ei-
ther directly by phagocytosis and intracellular destruction or by the release of toxic
mediators (Artavanis-Tsakonas et al., 2003; Malaguarnera and Musumeci, 2002).
Early recognition of parasites leads to increased production of pro-inflammatory
cytokines (IL-12, IL-1, and IL-6) necessary for activation and differentiation of other
immune competent cells, e.g. NK cells and CD4+ T cells. Although important for
Plasmodium clearance, macrophages contribute to a pro-inflammatory cytokine en-
vironment reinforcing adaptive immune reactions which might have deleterious
consequences for the host.
B cells
B cells have several different functions during infection. Their membrane bound
immune-globulins serve as receptors for antigen, which when bound to the anti-
body will be taken up by B cells, processed and presented to T cells. Additionally,
activation of B cells is induced after antibody-antigen recognition and interaction
with T cells and macrophages. Activated B cells differentiate and clonaly expand
generating plasma and memory cells. Plasma cells are able to produce secreted an-
tibodies with specificity to one epitope on an antigen. During infection, antibodies
bind to specific antigens on the pathogen, thus facilitating destruction by phago-
cytes. Vaccination studies describe B cells to influence blood stage Plasmodium in-
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fection in an antibody dependent manner (Good et al., 2005). Acute malaria is asso-
ciated with disruption of germinal centres in murine spleens (Carvalho et al., 2007)
and depletion of B cells in the marginal zone in lethal P. falciparum infections (Urban
et al., 2005). These data implicate a strong involvement of B cells in maintaining the
organized structure of the spleen, although a direct involvement of B cells in patho-
genesis of cerebral malaria has not been found (Yañez et al., 1996). However, the
role of B cells in antigen presentation has not been addressed and their role during
cerebral malaria has to be further elucidated.
Dendritic cells
Another set of antigen-presenting cells are dendritic cells. Linking innate and adap-
tive immune responses, mature dendritic cells presenting antigen potently stimu-
late naïve T cells. On the one hand, DCs can recognize and take up pathogens, pep-
tides are generated in intracellular vesicles, loaded into MHC class II molecules and
transported to the cell surface. On the other hand, dendritic cells can cross-present
protein-derived antigens, which are taken up from the extracellular environment,
processed and presented in an MHC class I context. Any infected nucleated cell
may present antigens from intracellular pathogens bound to MHC class I molecules
and thereby together with co-stimulatory signals induce effector function of CD8+
cytotoxic T cells. However, cross-presentation by dendritic cells greatly enhances
activation and expansion of effector T cells, which are critically involved in anti-
viral, anti-tumour immunity and in maintaining T cell tolerance to self antigens
(Kurts et al., 2010). Depending on the strain of Plasmodium, dendritic cells have
different functions during infection (Lundie, 2010). After Plasmodium chabaudi in-
fection, CD8− DCs present parasite antigens to CD4+ T cells and induce a shift
towards Th2 responses characterized by IL-10 and IL-4 cytokines in mice, thus pro-
viding effective help for blood-stage parasite specific antibody responses (Sponaas
et al., 2006). Nonetheless, CD8+ DCs cross-present P. berghei specific antigens to
CD8+ T cells (Lundie et al., 2008), but presentation is short-lived (Lundie et al.,
2010) and pro-inflammatory cytokines and T cell activity influence disease progres-
sion. deWalick et al. (2007) showed that conventional DCs are critically involved
in cerebral malaria after P. berghei infection. Information on human dendritic cells
8
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and their role in cerebral malaria is scarce and are mainly confined to ex vivo or
in vitro studies. Nonetheless, haemozoin, a parasite-detoxification product released
into the blood stream when infected erythrocytes rupture is known to inhibit mono-
cyte function and further differentiation into dendritic cells (Stevenson and Urban,
2006).
1.2.4 Toll-like receptors
Invading pathogens are sensed by the innate immune system of the host through
Toll-like receptors (TLRs). Pathogen associated molecular patterns (PAMPs) stimu-
late these pathogen recognition receptors (PRRs) inducing a variety of host defence
mechanisms (Takeda et al., 2003). Cellular distribution of TLRs depends on the
molecules recognized. Some are located on the cell surface to sense extracellular
pathogens, for example LPS from gram-negative bacteria binds to TLR-4. Intracel-
lular pathogens like viruses or intracellularly degraded micro-organisms are rec-
ognized in late endosomal compartments, e.g. TLR-7 senses the presence of single
stranded RNA motifs and TLR-9 binds to short unmethylated CpG motifs (Takeda
et al., 2003). Binding of PRRs to TLRs leads to the recruitment and phosporylation
of adapter proteins and subsequent signalling cascades induce transcription fac-
tors culminating in the production of inflammatory mediators. Most TLRs share
the adapter protein MyD88 and signalling leads to downstream activation of NF-
κB, inducing the expression of pro-inflammatory cytokines like IFN-γ and IL-12
(Wagner, 2004). Plasmodium derived glycosylphosphatidylinositol (GPI) is known
to stimulate TLR-2 and to a lesser extend, TLR-4; plasmodial DNA bound to haemo-
zoin is recognized by TLR-9 (Krishnegowda et al., 2005; Parroche et al., 2007). TLR-9
is expressed mainly by plasmacytoid and conventional DCs, but are also found on
B cells and macrophages. An involvement of TLR-9 signalling in CM pathogenesis
is debated, with some studies having shown that neuropathology is TLR-9 depen-
dent, while evidence from others argues against an influence of TLR-9 in disease
progression (Coban et al., 2007; Togbe et al., 2007; Lepenies et al., 2007). However,
human studies analysing host genetic factors found that single nucleotide polymor-
phisms (SNPs) in TLR-4 and TLR-9 predispose infected persons to severe malaria
(Leoratti et al., 2008; Mockenhaupt et al., 2006).
9
1 Introduction
1.2.5 Cytokines
Circulating cytokines such as tumour necrosis factor (TNF), interleukin-1 (IL-1),
interleukin-6 (IL-6), lymphotoxin (LT) and interferon-γ (IFN-γ) have been associ-
ated with the development of severe malaria (Artavanis-Tsakonas et al., 2003; Hunt
and Grau, 2003). Since inflammatory responses are recognized to be involved in
pathology, lymphocytes and inflammatory mediators have increasingly become the
focus of current research.
Interferon-γ
Interferon-γ, mainly produced by T and NK cells, induces activation of macro-
phages and subsequent microbicidal functions, increases MHC class I and II ex-
pression and enhances antigen presentation. Moreover, IFN-γ produced by Th1
cells is involved in antibody-class switching to protective IgG isotypes. This cy-
tokine is also associated with CD8+ T cell differentiation and involved in pro-
inflammatory responses. Presence of IFN-γ during Plasmodium infection has versa-
tile effects on the host. On the one hand IFN-γ is known to have anti-plasmodial
properties in P. chabaudi infection, stimulating macrophages to produce nitric oxide
(NO) and other toxic reactive oxygen radicals (Meding et al., 1990; Su and Steven-
son, 2000). On the other hand, IFN-γ has been linked to cerebral malaria devel-
opment, stimulating macrophages to exert anti-pathogenic activity and initiating
antigen-presentation in endothelial cells (Geppert and Lipsky, 1985; Galea et al.,
2007). In the absence of IFN-γ (Yañez et al., 1996) or IFN-γ- receptor (Amani et al.,
2000; Rudin et al., 1997) mice are resistant to CM development. Knock-out mice
showed reduced downstream effector functions like reduced intracellular adhesion
molecule (ICAM-1) expression, reduced indolamin-2,3-dioxygenase (IDO) activity
and overall reduced inflammatory reactions. Genetic studies in humans have re-
vealed that people with a certain polymorphism in the IFN-γ gene had a lower
incidence of CM. Some studies associate serum IFN-γ with development of severe
malaria and neuropathology, whereas others negatively correlated this cytokine to
acute malaria (Hunt and Grau, 2003; Malaguarnera and Musumeci, 2002; McCall
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and Sauerwein, 2010). Thus the exact role of IFN-γ in malaria disease is still to be
described.
Interleukin-12
Production of IFN-γ is induced by IL-12, a pro-inflammatory cytokine produced
by dendritic cells and phagocytes upon TLR stimulation. IL-12p40 and IL-12p35
subunits comprise the heterodimeric IL-12p70 protein, signalling through the IL-12
receptor, which itself is composed of two chains (IL-12R-β1 and IL-12R-β2). Sev-
eral cytokines belong to the IL-12 super-family sharing different subunits and re-
ceptors (Trinchieri, 2003). The IL-12p40 subunit together with IL-23p19 builds IL-
23, whereas IL-12p35 and Ebi3 make up IL-35 (figure 4.1). IL-12p40 can also be
found as a homodimer to form IL-12p80, which is described to have regulatory
functions (Holscher, 2004). However, IL-12p70 is critically required for induction
of IFN-γ production by NK cells and both cytokines are needed for Th1 cell dif-
ferentiation and generation of cytotoxic CD8+ T cells. Although IL-12 plays a cen-
tral role in cell-mediated immune responses to induce parasite clearance, parasites
and increased TLR-9 stimulation is reported to paralyse DC maturation dampen-
ing pro-inflammatory immune responses facilitating parasite survival and reducing
immune-mediated damage (Reis e Sousa et al., 1999; Wingender et al., 2006; Urban
et al., 2001). While IL-12 is known to be involved in strong pro-inflammatory re-
actions, in P. falciparum infection severity of disease is actually correlated to lower
levels of IL-12 (Malaguarnera et al., 2002), and a heterozygous polymorphism in the
promotor region of the IL-12B gene (encoding IL-12p40) has been associated with
reduced IL-12 protein in serum samples that conferred an associated increased risk
of CM development (Marquet et al., 2008).
Lymphotoxin
The tumour necrosis factor (TNF)/tumour necrosis factor receptor (TNF-R) super-
family comprises several cytokines with a variety of functions in immune responses.
Two members of this family lymphotoxin-α (LT-α) and lymphotoxin-β (LT-β), de-
spite their similar structures, have distinct roles in innate and adaptive immunity.
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A common signalling network involves five distinct receptors which are shared
between TNF-family cytokines and exert overlapping biological functions (Ware,
2005). Secreted mainly by activated lymphocytes like T cells, but also by macro-
phages and dendritic cells, LT activates and induces NO production, TNF activates
vascular endothelium and increases permeability leading to local and systemic in-
flammation. Besides their involvement in immune responses, these cytokines and
their receptors are required for lymphoid organ development. In the absence of
lymphotoxin-β or LT-βR, development of the splenic architecture is disrupted and
the migratory properties of DCs are impaired. Similar effects are seen in the ab-
sence of other TNF family members (Alimzhanov et al., 1997; Ware, 2005; Fütterer
et al., 1998). Cerebral malaria pathology has been associated with increased serum
levels of TNF and a single nucleotide polymorphism within the TNF promoter re-
gion correlated with greater cytokine transcription, conferring a higher risk of neu-
ropathology (Hunt and Grau, 2003; Randall and Engwerda, 2010). Experimental
data from murine cerebral malaria models, however, reinforce the importance of
lymphotoxin rather than TNF in disease progression since the development of ECM
required functional TNF and LT receptors (Togbe et al., 2008; Randall et al., 2008).
Nonetheless, as LT-βR deficient mice have a disrupted splenic micro-architecture a
failure to generate effector T cells may be hold responsible for the absence of neu-
ropathology.
1.2.6 T cells
T cell responses of the adaptive immune system require processed antigens of in-
vading pathogens for activation and effector functions. T cells recognize corre-
sponding peptides bound to MHC molecules through their T cell receptor (TCR).
T cells can be divided into two groups distinguished by surface expression of co-
receptor molecules CD4 and CD8. Together with T cell receptors, CD4 and CD8
determine effector function of the cell. T cells expressing CD4, recognize antigens
presented in an MHC class II context and differentiate into T helper (Th) cells that
can be categorized into two main subsets, Th1 and Th2 cells. Cytokine environment
influences differentiation into either subset, IL-12 induces Th1 differentiation, while
e.g. IL-4 is responsible for e.g. Th2 development. Th1 and Th2 subsets have differ-
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ent functions during immune responses. Th1 pro-inflammatory cytokines like IFN-
γ, IL-12 and TNF assist in cell mediated immunity by activating DCs, macrophages
and cytotoxic T cells. Excessive inflammation and tissue damage can also be asso-
ciated with this subset. Th2 cells secrete IL-4 and IL-5 thereby promoting antibody
dependent responses and activation of eosinophils.
Plasmodium induced cytokines like TNF and IFN-γ skew the differentiation of CD4+
cells into Th1 cells. These cells are discussed to reduce parasite burden, but also
promote disease in a murine Plasmodium infection (Hirunpetcharat et al., 1999).
Moreover, early interactions between NK cells and P. falciparum parasites induce
activation and function of CD4+ T cells in vitro, possibly assisting in parasite clear-
ance (Horowitz et al., 2010; Horowitz and Riley, 2010). Association of CD4+ T cells
with cerebral malaria is confined to the mouse model, in which these cells have
been shown to contribute to neuropathology (Belnoue et al., 2002; Yañez et al., 1996;
Amante et al., 2010).
Secreted cytokines like IFN-γ and IL-12 from Th1 cells participate in activation
of cytotoxic CD8+ T cells, thereby supporting clearance of pathogens through cy-
tokine secretion, phagocyte activation and cytotoxic activity. However, if not tightly
controlled, CD8+ T cells can be involved in tissue destruction. Naive CD8+ T
cells encounter antigen bound to MHC class I molecules on the surface of antigen-
presenting cells like dendritic cells and macrophages. Recognition and co-stim-
ulation leads to maturation and clonal expansion before antigen-specific effector
functions take place. Although, efficiently clearing virus infections, during ECM
pathogenic T cells mediate blood brain barrier disruption by sequestration to en-
dothelial cells with the resulting perforin-mediated destruction of the same (Nitcheu
et al., 2003). The predominant role of CD8+ T cells in ECM pathology was shown
in depletion experiments performed by Belnoue et al. (2002) and Renia et al. (2006),
which showed that depletion six days post infection and shortly before onset of CM
development rescued WT mice from neurological disease and subsequent death.
Moreover, RAG2−/− mice, which lack mature lymphocytes, do not develop neu-
rological complications as seen in BL/6 WT mice (Finley et al., 1982; Grau et al.,
1986; Yañez et al., 1996). However, reconstitution with primed effector T cells re-
versed protection from ECM (Nitcheu et al., 2003). The role for effector T cells
during human cerebral malaria has not been evaluated systematically, as sample
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retrieval is constrained by obvious ethical reasons. However, studies performed
in the mid 1980s reported an increased frequency of circulating CD8+ T cells in P.
falciparum infections (Troye-Blomberg et al., 1984; Stach et al., 1986). Early interac-
tions of APCs with effector T cells in the spleen, as well as antigen-specific immune
responses during Plasmodium infection and neuropathology are insufficiently in-
vestigated, requiring further investigations.
1.3 Aims and Objectives
Cerebral malaria has been proposed to be the result of excessive immune mediated
reactions induced by Plasmodium infection. Some factors and cells are known to be
involved in blood brain barrier (BBB) disruption and neuropathology. Time, origin
and cellular and molecular factors involved in early immune responses priming ef-
fector T cells, responsible for the pathogenesis of cerebral malaria, have not been
well investigated. Immunopathology has more than one cause and depends on the
interaction of several factors. In this work the spleen as an immunologic compart-
ment involved in early priming of pathogenic responses during experimental cere-
bral malaria was elucidated.
Moreover, macrophages, B cells and dendritic cells that compose the highly or-
ganised architecture of the spleen and their involvement in effector cell generation
were analysed in this study.
1. It is well known that effector T cells are critically involved in disease pro-
gression of cerebral malaria. Our study aimed to elucidate if detrimental re-
sponses were a result of unspecific hyper-reactive T cell responses or if effec-
tor T cells were directed specifically towards parasite antigens, and were thus
restrictively involved in neuropathology?
2. T cell priming towards blood-bourne antigen takes place in the spleen. It
is known that the spleen is involved in detrimental immune responses and
splenectomy is described to reduce the incidence of cerebral malaria in sus-
ceptible mice. Is the cellular organisation and an intact micro-architecture a
necessity for early priming events during Plasmodium infection and are cells
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maintaining the splenic structure of importance in generation of antigen-
specific T cell responses and subsequent pathogenesis?
3. Antigen-presentation and specific priming of T cells is a requirement for effec-
tive T cell responses. Which cells in the spleen participate in antigen presen-
tation and parasite-specific cytotoxic T cell generation? Are interactions be-
tween macrophages, dendritic cells and B cells, all of which reside within dis-
tinct compartments in the spleen, responsible for priming of CD8+ responses
leading to cerebral malaria?
4. The activation of antigen-presenting cells is dependent on parasite recogni-
tion through TLRs. This in turn leads to production of cytokines like IL-12
required for the activation of CD4+ T cells. Therefore the question arose, is
parasite recognition through TLR-9 and subsequent IL-12 production impor-
tant during P. berghei infection and is TLR-9 stimulation and IL-12 signalling
involved in T cell priming? Another prerequisite for APC and T cell activation
is the help of CD4+ T cells, which are activated by IL-12. During Plasmodium
infection, is CD4 T cell help involved in effector T cell generation and blood-
brain barrier disruption and neuropathology?
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2.1 Material
2.1.1 Animal maintenance
C57 BL/6 mice were obtained from Janvier (Le Genest Saint Isle, France), Charles
River Laboratories (Sulzfeld, Germany), our own animal facility or the House of
Experimental Therapy (HET, Bonn). All mice were kept in animal facilities of the
institute and were provided with food and water ad libitum.
2.1.2 Buffers and solutions in alphabetical order
Anaesthesia: longterm
Rompun 23,32 mg/ml( Bayer, Leverkusen, Germany) 10 µl
Ketanest 50 mg/ml (Medistar, Ascheberg, Germany) 10 µl
PBS 1x (PAA Laboratories, Austria) 30µl
50 µl injected intra muscular (i.m.)
Anaesthesia: short-term
Inhalation of Isofluran (Abbott, Wiesbaden, Germany )for 30-90 seconds.
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Antibodies
ELISA
Antibodies and corresponding recombinant protein for cytokine ELISA were pur-
chased from BD Pharmingen (Heidelberg, Germany).
IFN-γ ELISA
Capture antibody R4-6A2, 2µg/ml
Detection antibody MG1.2, 1µg/ml
Recombinant protein 19301T
FACS
For FACS-staining of murine surface-molecules or intracellular cytokines, the fol-
lowing antibodies were purchased from BD Pharmingen or eBiosciences. All anti-
bodies were either biotinylated or labelled with a fluorochrome (FITC, PE or APC)
and used in amounts previously determined by titration. The antibodies were di-
rected against the following murine epitopes (clone names are given in parenthe-
ses): anti-CD8α (53.-6.7), anti-IFN-γ (R4-6A2) Fc receptors were always blocked
by adding 2.4G2 (rat) antibody. H-2kb/SIINFEKL tetramers labeled with fluo-
rochromes were purchased from ProImmune.
Depletion
GK1.5 antibody to deplete CD4+ T cells was kindly provided by the Institute of
Molecular Medicine, Bonn.
Cell culture media
All reagents, unless otherwise stated, were purchased from PAA Laboratories.
BMDCs were cultured in IMDM supplemented with 10% FCS, 2 mM Glutamine,
100 IU/ml Penicillin and 100 µg/ml Streptomycin. Splenocytes and brain lympho-
cytes were cultured in RPMI 1640 supplemented with 10% FCS, 2 mM Glutamine,
100 IU/ml Penicillin and 100 µg/ml Streptomycin. Work was carried out under
sterile conditions and solutions were kept sterile at 4◦C.
17
2 Material and Methods
Collagenase A buffer
50 mg/ml collagenase type I A (Clostridium histolyticum) from Sigma Aldrich GmbH,
Munich, was diluted 1:125 in 1x PBS.
CFSE stock
5,6-Carboxy-Succinimidyl-Fluoresceine-Ester (CFSE, Invitrogen, Darmstadt, Ger-
many) was dissolved in DMSO (10 mM) and stored in 10 µl aliquots at –20◦C.
EDTA 200 mM
18.61 g Ethylendiamintetraacetat (EDTA) (C10H14N2O8Na2· 2H2O) was dissolved
in 250 ml ultra-pure water and adjusted to pH 8.0 with NaOH. The solution was
autoclaved and stored at room temperature.
ELISA buffer
Coating buffer 0.1 M Na2PO4 in aqua bidest, pH 9.0
Washing buffer 1 M PBS, 0.05% Tween (Sigma Aldrich GmbH)
Blocking solution 1 M PBS with 1% BSA (Roth, Karlsruhe, Germany)
Substrate buffer 0.1 M NaH2PO4·H2O, pH 5.5
Substrate 60 mg 3,3‘,5,5‘Tetramethylenbenzidine
(Roth) dissolved in 10 ml DMSO
Substrate solution 10 ml substrate buffer
200 µl substrate and 2 µl H2O2
Stop solution 2 M H2SO4
FACS buffer
1x PBS containing 1% FCS, prepared under sterile conditions and stored at 4◦C.
FarRed stock
FarRed (Invitrogen) was dissolved in DMSO (1 mM) and stored in 10 µl aliquots at
-20◦C.
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MACS buffer
1x PBS containing 1% FCS and 2mM EDTA was stored under sterile conditions at
4◦C.
NaCl
Diaco, Serag Wiessner KG, Naila, Germany.
PBS - Phosphate buffered saline
PAA Laboratories, Austria
Peptides
Peptides were obtained from Pineda (Berlin, Germany), dissolved in DMSO for 20
mM stock solutions and stored at -20◦C.
Origin Name Sequence MHC Haplotype
OVA S8L SIINFEKL H-2kb
MSP
F8L FITKFEEL H-2kb
L8L LGITYKSL H-2kb
D10L DGLQNIYAEL H-2db
K10L KPIENIQDDI H-2db
T10L TELVNLIKTL H-2db
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2.1.3 Equipment
Spectra-photometer
Platereader
Spectra MAX 340PC, MTX lab systems, Virginia, USA
Flow Cytometer FACS Canto, BD biosciences, Heidelberg, Germany
Cell counter CASY TT R© , Schärfe System, Reutlingen, Germany
Centrifuge Heraeus Multifuge 4 KR - LH-4000 Rotor, Kendro Lab-
oratory Products GmbH, Hanau, Germany
2.1.4 Computer software
Data processing Open Office Calc (Sun Microsystem Inc.)
Statistical analyses Graph Pad Prism 5.0 (Molecular Devices, Sunnyvale,
USA)
PASW 18 (IBM, New York, USA)
FACS FACSDiva Software (BD Pharmingen, Heidelberg,
Germany)
FlowJo Software (Treestar Inc., Ashland, USA)
2.2 Methods
2.2.1 Identification of H-2kb and H-2db specific peptides from
Plasmodium berghei MSP-1
MSP-1 specific peptides were searched with SYFPEITHI, a database of MHC ligand-
and peptide motifs. The NCBI amino acid sequence (NCBI Reference: XP_678505)
of P. berghei merozoite surface protein-1 (MSP-1) was placed into the database of
SYFPEITHI. Our model of interest was the C57 BL/6 mouse, in which MHC class
I molecules have the H-2kb or H-2db haplotype. Length of the peptides was set to
8-10 amino acids, the optimal size for the MHC class I peptide binding groove. Pep-
tides with the best binding properties were selected and synthesized from Pineda
(Berlin, Germany).
20
2 Material and Methods
2.2.2 Experimental animal handling and knock-out mice
Starting day four post infection, mice were punctured in the tail vein for daily
blood-smears. Before day 4, parasite levels were almost undetectable (1 dpi and
2 dpi) or very low (3 dpi). For evaluation of disease onset, mice were monitored
twice daily for ECM symptoms. ECM development was scored according to the
following symptoms: 0= without symptoms, 1= ruffled fur, 2= hunching, 3= wob-
bly gait, 4= limb paralysis, 5= convulsions, 6= coma (Amante et al., 2007).
Table 2.1: Mouse strains
Strain Phenotype Reference
CD11c-DTR-OVA-GFP tg Express under CD11c
promoter human Diphtheria
toxin receptor and express
OVA and GFP
N. Garbi, Heidelberg
CD19-DTR- tg Express under CD19
promoter human Diphtheria
toxin receptor and express
OVA and GFP
Buch et al. (2005)
IL-12p35−/− IL-12 deficient Cousens et al. (1999)
IL-12p35/p40−/− IL-12 and IL-23 deficient Provided by G. Alber,
Leipzig
IL-12p40−/− IL-12 and IL-23 deficient Provided by G. Alber,
Leipzig
IL-23p19−/− IL-23 deficient Provided by G. Alber,
Leipzig
IL-12Rβ1−/− Deficient in IL-12 signalling Provided by M.
Freudenberg,
Freiburg
RAG1−/− Lack B and T cells Provided from
IMMEI
TLR-9−/− TLR-9 deficient Hemmi et al. (2000)
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2.2.3 Plasmodium berghei infection
In all experiments P. berghei infected red blood cells (pRBCs) were used to inocu-
late mice. Mice were infected intravenously (i.v.) with 5x104 pRBCs obtained from
mice that had been previously infected intraperitoneally (i.p.) with stock solution.
Stock solution contained 1x107 iRBCs in glycerine and was stored in liquid nitro-
gen. Stock mice were of the same background as experimental animals. Experi-
ments were conducted with either P. berghei ANKA (PbA) or P. berghei expressing
OVA (PbTG). The latter was kindly provided by Rachel Lundie (Lundie et al., 2008).
Experimental setup and Plasmodium strains used are denoted in the figure caption
or results section.
2.2.4 Splenectomy and autotransplantation
Splenectomy was performed seven to five days prior to infection (SplX). Splenic
pedicles were ligated and subsequently severed. Then the spleen was removed
and the body wall and skin sutured. For autotransplantation (AT), the spleen was
placed in a dish with sterile PBS and cut into pieces of equal size. The pieces were
then re-implanted into the same animal by placing them in the renal pelvis. During
the whole procedure mice were anaesthetised with Isofluran (Abbott).
2.2.5 Adenovirus infection
1x108 pfu of Adenovirus type 5 expressing ovalbumin (AdOVA) was administered
i.v. 6 days prior to analysis.
2.2.6 Depletion of cell types
Macrophages
Macrophages were depleted at one day prior to infection (d-1) and 4 days after
parasite inoculation (4 dpi) by intravenous injection of 0.2 ml of PBS containing ap-
proximately 1 mg of dichloro-methylenediphosphonate (Cl2-MDP) encapsulated in
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liposomes (kindly provided by Nico van Rooijen, Faculty of Medicine, Amsterdam
University, Amsterdam, The Netherlands).
Dendritic cells
CD11c DTR OVA GFP mice were injected i.p. with 40 ng/g diphtheria toxin (DTX)
(Sigma-Aldrich GmbH) dissolved in 100 µl NaCl. Treatment regimen was on a daily
basis, starting d0 and ending d4 p.i. with P. berghei.
B cells
CD19 DTR OVA GFP mice were injected i.p. with 40 ng/g diphtheria toxin (DTX)
(Sigma-Aldrich GmbH) dissolved in 100 µl NaCl. Treatment regimen was on a daily
basis, starting d0 and ending d4 p.i. for early depletion, and d4 till d7 p.i. for late
depletion.
CD4+
100 µl GK1.5 antibody was given i.p. one day post infection or 5 days post infec-
tion.
2.2.7 Perfusion and lymphocyte isolation
In order to analyse lymphocytes that were sequestered to vascular endothelium or
extravasated into the brain tissue, long-term anaesthetised mice were intracardially
perfused for 5 minutes with 1x PBS. Spleens and brains were removed, placed in
MACS buffer or collagenase A buffer, respectively, and placed on ice. Spleens were
gently pressed through a sieve, washed with 1x PBS containing 1% FCS and 2 mM
EDTA and centrifuged (10 min., 1500 rpm with the Heraeus Multifuge 4 KR), cell
numbers were determined with the CASY R© TT cell counter (Schärfe Systems). Cells
were adjusted to 2x107 per ml medium, and 50 µl were plated into 96 well plates.
Brain tissue was cut into small pieces and incubated in 2 ml collagenase A buffer
for 30 min. at 37◦C in a water bath. MACS-buffer was added to the tissue, which
was then homogenized to a single cell suspension using a metal sieve. Cells were
then centrifuged at 1500 rpm for 8 min. at 4◦C. The cell pellet was suspended in
5 ml 30% Percoll that was then layerd onto a two step Percoll gradient made of 3
ml 37% Percoll and 3 ml 70% Percoll. Samples were centrifuged at room temper-
ature for 20 minutes without brakes at 2000 rpm (Heraeus Multifuge 4 KR). After
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percoll separation, two white interphases were isolated and transferred into a fresh
tube and washed with MACS buffer. After a second centrifugation step, cells were
resuspended in 1 ml RPMI. Cells were counted with the CASY R© TT cell counter.
(10 µl in 10 ml). Peptides (OVA or MSP-1) were added in a final concentration of 2
µM.
2.2.8 Generation of bone marrow derived dendritic cells (BMDCs)
Hind legs from naive C57 BL/6 donor mice were cut at the pelvis and disinfected
with ethanol. After removal of skin and muscle tissue, bones were washed in ster-
ile PBS. The ends of the bones were cut off and bone marrow was flushed with
a PBS-filled syringe into 50 ml Falcon tubes. Cells were then washed with PBS,
centrifuged for 10 minutes, 1500 rpm at 4◦C (Heraeus Multifuge 4 KR) and resus-
pended in GM-CSF (PANTM Biotech GmbH, Aidenbach, Germany) complemented
IMDM medium. The suspension was adjusted to 5x105/ml and 10 ml were plated
on to sterile petri dishes. After four days cells were incubated for 2 minutes with 2
mM EDTA at 37◦C, all cells were transferred into a new 50 ml tube and washed with
sterile PBS and centrifuged for 10 minutes at 4◦C . After resuspension in IMDM
supplemented with GM-CSF cells were re-plated. Seven days after culture BMDCs
were harvested and co-cultured with splenocytes or brain lymphocytes for 24 hours
in RPMI.
2.2.9 Cell culture
1x106 splenocytes or 1x 105 brain lymphocytes were co-cultured with 1x106 BMDCs
in 96-well culture plates (Greiner) at 37◦C and 5 % CO2 for 24 hours. Supernatants
were taken for cytokine analysis and stored at -20◦C until needed.
2.2.10 Evans Blue Assay to detect BBB disruption
Six days p.i. with P. berghei mice were injected intravenously with 200 µl 2% Evans
Blue (Sigma Aldrich, St. Louis, USA). Mice were sacrificed one hour later and
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brains were isolated to assess vascular leakage of the dye into the brain parenchyma.
After photo documentation, brains were weighed and incubated in 2ml formamide
for 48h at 37◦C. 100 µl of the solution were analysed in triplicate on a microtiter
plate. Absorbance was measured at 620nm in an ELISA reader. Concentration of
Evans Blue was calculated with a standard curve (200- final point µg/ml) and is
expressed as µg Evans Blue per gram brain tissue.
2.2.11 In vivo cytotoxicity assay
Five days after infection, cytotoxicity of antigen-specific CD8+ T cells can be mea-
sured. Intravenously administered splenocytes (target cells) from syngenic donors,
were labeled with antigen-specific class I peptides and lysed by antigen-specific cy-
totoxic T lymphocytes (CTLs) of infected animals. The target cells were labelled
with CFSE to allow visualization via flow cytometry. Target cells were pulsed
with OVA class I peptide SIINFEKL (1 µM) or a MSP-1 peptide mix containing
F8L, K10L, T10L, D10L peptides (1 µM), samples were incubated for 15 minutes at
37◦C. Subsequently cells were labelled with 1 µM CFSE or FarRed (high). These
target cells should be recognized by CTLs. Reference cells without peptide were
labelled with 0.1 µM CFSE. The amount of reference cells should remain stable as
they should not be recognized by immune cells. Staining took place at 37◦C for 30
minutes. After two washing steps cells were counted and mixed 1:1:1 from each
population. Intensity of CFSE labelling, was analysed via flow cytometry by mix-
ing 50 µl of each sample and 50 µl of unlabelled cells together. Peptide loaded cells
(1 µM dye) and reference cells (0.1 µM dye) should differ by one log-step in the
mean fluorescence intensity (MFI), whereas the difference between unlabelled cells
and reference cells should be 1.5 to 2 log steps. Mice were injected i.v. with 5x106
target cells from each colour and the same amount of reference cells. After 18 hours
spleens were removed and homogenised. The ratio of lysed target cells to reference
cells was determined by flow cytometry. To calculated specific cytotoxicty follow-
ing formula was used:
specific cytotoxicity % = 100 – (CFSEhigh ÷ CFSElow) of immunized animal ÷
(CFSEhigh ÷ CFSElow) of naïve control x 100
and for FarRed labelled cells:
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specific cytotoxicity % = 100 – (FarRedhigh ÷ CFSElow) of immunized animal ÷
(FarRedhigh ÷ CFSElow) of naïve control x 100
2.2.12 Enzyme Linked Immunosorbent Assay (ELISA)
Cytokines in the supernatant were measured by specific sandwich ELISA using mi-
crolon high bonding microtiter plates (Greiner Bio One, Frickenhausen, Germany).
Antibodies were used according to standard protocol provided by the company.
Briefly, plates were incubated over night at 4◦C with 50 µl coating antibody diluted
in coating buffer. Following two washes with wash buffer, plates were incubated
with 150 µl/well blocking solution for one hour at room temperature and washed
again. 50 µl/well of samples and a series of standards, diluted in 1% BSA-PBS were
added and incubated over night a 4◦C. After five washes, 50 µl biotinylated detec-
tion antibodies diluted in 1% BSA-PBS were added to each well. After 60 minutes
incubation, plates were washed five times, and incubated with 50 µl streptavidin-
peroxidase complex (1:5000, Boehringer, Mannheim, Germany) for 45 minutes at
room temperature. After five washes 50 µl substrate solution was added to each
well. The reaction was stopped after colour development by addition of 50 µl
stop solution. Plates were read at 450nm using a Spectra Max 340 Microwellreader
(Molecular Devices, Sunnyvale, California, USA). Concentration was determined
from the standard curve.
2.3 Statistical analysis
Graphpad Prism 5.0 software was used for data organisation and statistical anal-
ysis, additionally PASW 18.0 software was used for statistical calculations. Differ-
ences in survival between groups were calculated with the Mantel-Cox log-rank
test. ECM scores over time are presented as median and range. Statistical differ-
ences for three or more groups of IFN-γ levels in the supernatant (displayed as
µg/ml), Evans Blue leakage (displayed as µg/g brain tissue), and cytotoxicity (dis-
played as % cytotoxicity) were determined with Analysis of Variance (ANOVA)
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with the Bonferroni post-hoc test. For the comparison of two groups the Student-
t Test was chosen. P-values < 0.05 were considered significant. Unless otherwise
stated data is displayed as mean.
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3 Results
3.1 Antigen-specific immune responses during PbA
induced ECM
Immune mediated damage has been described to be critically involved in the devel-
opment of neuropathology in cerebral malaria. The relevance of adaptive immunity
contributing to pathology, especially the involvement of T cells has been known for
a while. Especially CD8+ T cells are responsible for fatal neurologic complications
and immune mediated damage in the brain. However, the precise mechanisms of
CD8+ T cell participation in the pathogenesis of cerebral malaria are still unclear.
The place and time of Plasmodium-induced CD8+ T cell generation and subsequent
responses involved in cerebral malaria were of particular interest in this study.
3.1.1 Identification of H-2kb specific peptides of PbA MSP-1
In order to study antigen-specific T cell responses, parasite specific peptides needed
to be identified. P. berghei merozoite surface protein-1 (MSP-1) was selected to gen-
erate immunogenic peptides. Peptides were searched with SYFPEITHI, a database
of MHC ligands and peptide motifs. Our model of interest was the C57 BL/6
mouse, in which MHC class I molecules have the H-2kb or H-2db haplotype. Five
peptides (table 3.1) predicted to be presented by the respective MHC haplotypes
were selected and synthesized. Splenocytes from PbA infected mice co-cultured
with BDMCs were restimulated with these five peptides and IFN-γ levels in the
supernatant were examined with ELISA. All peptides stimulated parasite-specific
T cells, as naive mice did not show increased IFN-γ levels (data not shown).
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Table 3.1: Selected MSP-1 specific peptides
Name Sequence MHC Haplotype
F8L FITKFEEL H-2kb
L8L LGITYKSL H-2kb
D10L DGLQNIYAEL H-2db
K10L KPIENIQDDI H-2db
T10L TELVNLIKTL H-2db
3.1.2 Antigen specific cytotoxic T cells in ECM
To investigate the presence of parasite specific T cells in spleen and brain during P.
berghei infection, isolated lymphocytes from naïve or infected C57 BL/6 mice were
analysed for IFN-γ production after restimulation with MSP-1 peptides presented
in a MHC I dependent manner. Plasmodium infection induced the generation of
IFN-γ producing CD8+ T cells in the spleen (figure 3.1a) and increased CD8+T
cell numbers in the brain (figure 3.1c) 6 days post infection (dpi), the same time
when first symptoms of cerebral malaria occurred. To analyse antigen-specificity,
splenic or brain lymphocytes from naïve or PbA infected mice (WT) were incubated
with peptide loaded BMDCs and analysed for IFNγ production after 24 hours. Af-
ter restimulation with the MSP-1 derived peptide D10L, IFN-γ levels in the super-
natant of splenocytes (figure 3.1c) derived from PbA infected mice were increased
(p<0.0001). This strongly suggests the presence of antigen specific CD8+ T cells.
Brain lymphocytes from diseased mice produced ten times higher amounts of IFN-
γ after restimulation with D10L than brain lymphocytes from healthy naïve ani-
mals (figure 3.1d). In order to analyse antigen-specific cytotoxicity, the transgenic
Plasmodium strain expressing ovalbumin PbTG (Lundie et al., 2008) was used to
infect C57 BL/6 mice. This strain was of great advantage for our experiments as
it expresses the model antigen ovalbumin in addition to parasite specific proteins.
MHC class I peptides SIINFEKL (S8L) from OVA, or MSP-1 specific peptides K10L,
D10L and F8L are presented by the C57 BL/6 MHC class I haplotypes H-2kb and
H-2db. Syngenic target cells were labelled with either S8L or a mixture of MSP-1
specific peptides and transferred to recipient mice, which had been infected for five
29
3 Results
Figure 3.1: Antigen specific CD8+ T cells can be detected in spleen and brain.
6 days post PbA infection splenocytes and brain lymphocytes were isolated from naive
or PbA infected WT mice (n=4). Spleen CD8+ cells from naive and PbA infected WT
mice analysed by FACS (a). IFN-γ released from spleen CD8+ cells incubated with
BMDCs from naive C57 BL/6 donors restimulated with D10L (b). Brain CD8+ cells
from naive and PbA infected mice analysed by FACS (c). Same as b but for brain
lymphocytes (d). IFN-γ levels are displayed as mean p<0.0001 (Student-t Test). One
representative data set shown in each panel.
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days with PbTG. 18 hours after cell transfer lytic activity of T cells was analysed
with an antigen-specific in vivo cytoxicity assay. In the presence of antigen-specific
CD8+ T cells the target cells were lysed, giving insights on effector T cell generation
and their activity during infection.
Figure 3.2: antigen-specific cytotoxic CD8+ T cells are present in the spleen of Plas-
modium berghei infected mice
In vivo cytotoxicity assay was performed in C57 BL/6 naïve (n=4), PbA (WT) (n=6) or
AdOVA (n=2) infected mice 6 dpi . MSP-1 or S8L labelled syngenic target cells were in-
jected 18h prior to analysis. H-2kb specific lysis of S8L labelled (a) or MSP-1 labelled (b)
target cells was measured with flow cytometry. Specific lysis depicted as mean p<0.01
tested with ANOVA and adjusted with Bonferroni post-hoc test.
Mice infected with OVA expressing Adenovirus (AdOVA) at d0 were included as
positive controls. In AdOVA infected control mice lysis of S8L labelled cells was
around 90%, whereas T cells from naive mice did not show any lytic activity
(p<0.001). In WT (PbTG infected) animals cytotoxic activity was lower (30%) than
in AdOVA control, lytic capacity was considerably increased compared to naive an-
imals (p<0.01) (figure 3.2a). Moreover, for the first time parasite-specific cytoxocity
was detectable in Plasmodium berghei OVA (PbTG) infected, cerebral malaria posi-
tive mice. 80% of the syngenic target cells (H-2kb) loaded with MSP-1 derived pep-
tides (K10L, D10L, F8L) were eliminated (figure 3.2b), whereas T cells from naïve
mice did not show any specific lytic activity (p<0.001). The detection of parasite-
specific cytotoxic CD8+ effector T cells propose an involvement of antigen-specific,
cytotoxic CD8+ T cells in the pathogenesis of cerebral malaria.
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3.2 Immune responses against Plasmodium berghei are
generated in the spleen
During blood stage infection with Plasmodium spp., the spleen functions as an im-
portant lymphoid organ, where infected erythrocytes are removed from the blood
stream and T and B cell responses are generated. Clearance of parasitized ery-
throcytes leads to possible antigen uptake by antigen-presenting cells (APCs), e.g.
macrophages, but also dendritic cells and B cells. These cells in turn are capable
of inducing the maturation and activation of effector T cells. The involvement of
the architecture and cells associated with the structure of the spleen in the priming
of CD8+ T cells and disease progression, the splenic compartment as a whole and
single cell types (macrophages, B cells and dendritic cells) were removed before or
during Plasmodium infection.
3.2.1 The intact structure of the spleen is critically involved in
disease progression and T cell activation
Splenectomy was one tool to prove the hypothesis that the spleen as a lymphoid or-
gan is of importance in the pathogenesis of cerebral malaria. One week after surgi-
cal removal of the spleen, mice were infected with 5x104 PbA infected erythrocytes
(iRBCs) and ECM development and survival was monitored. The removal of the
spleen resulted in ameliorated or absent neuropathology (data not shown) as well
as in significantly increased (p<0.0001) survival (figure 3.3a). Mice died between
day 20 and day 30 post infection from hyperparasitaemia, anaemia or metabolic
dysfunction. In a different infection model, with OVA expressing recombinant Ade-
novirus, Beatrix Schumak (PhD Thesis) has shown that without the spleen cytotoxic
T cell lysis was absent. PbA infected splenectomised mice did not show any signs
of neuropathology, indicating that immunological events in the spleen are critically
involved in ECM pathogenesis. Brain lymphocytes of splenectomised mice showed
reduced IFN-γ production after co-culture with BMDCs and restimulation with S8L
compared to IFN-γ levels in infected WT mice and IFN-γ levels were similar to the
background levels of naive mice (figure 3.3c).
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Figure 3.3: Presence of an intact spleen is required for ECM and activity of antigen-
specific T cell responses
C57 BL/6 WT were infected with Plasmodium berghei ANKA, indicated groups were
splenectomised or autotransplanted one week prior to infection. Survival was mon-
itored in WT, splenectomised (SplX) (a and b) and in autotransplanted (AT) mice (b).
Differences in survival were calculated with Log-rank Test. IFN-γ production after S8L-
specific restimulation of brain lymphocytes on BMDCs (c) and Evans Blue leakage into
brain parenchyma (d) was analysed six days post PbTG infection. Data is displayed
as mean, statistical analysis with ANOVA and Bonferroni post-hoc test did not reach
p<0.05.
Blood brain barrier disruption and intra-cerebral infiltration, measured by Evans
Blue leakage into brain parenchyma was decreased in mice lacking the spleen (fig-
ure 3.3d), supporting the hypothesis that the spleen as a lymphoid compartment is
critically involved in the generation of detrimental immune responses.
3.2.2 Autotransplantation of the spleen reverses protection
In the absence of the spleen, mice were unable to mount an immune response
against the parasite. In parallel, antigen-specific T cells were absent in the blood
33
3 Results
and brain, and blood brain barrier (BBB) disruption as well as neuropathology
were undetectable. To further analyse the unique functions of the spleen regarding
its complex architecture and its pivotal role as a lymphoid organ in ECM, splenic
pieces were implanted into splenectomized mice prior to PbA infection and para-
sitological and immunological parameters were assessed. A post-mortem study of
splenectomised mice showed that the implanted spleen pieces were revascularised
6 days after surgery. Autotransplanted Plasmodium infected mice showed decreased
survival comparable to WT mice (figure 3.3b).
Furthermore, brain lymphocytes from autotransplanted mice produced increased
amounts of IFN-γ after restimulation with S8L than the restimulated lymphocytes
of splenectomised Plasmodium infected mice. Cytokine levels in restimulated brain
cells after retransplantation were half the levels found in WT mice (figure 3.3c). Al-
though T cell responses were present, Evans Blue leakage into brain parenchyma
was reduced in autotransplanted mice. ECM positive WT mice had tissue concen-
trations of the dye twice as high as those in autotransplanted mice (figure 3.3d).
Revascularised pieces of the spleen were sufficient for generating detrimental par-
asite specific immune responses, adding evidence to the hypothesis that the spleen
is an important source of inflammatory cells and substantially involved in ECM
pathogenesis.
3.2.3 The splenic architecture is involved in T cell priming and
disease progression
Further evidence for the importance of the spleen could be elucidated in mice
with perturbed cellular structure in this organ. Mice lacking mature lymphocytes
(RAG2−/−) as well as mice genetically deficient in lymphotoxin-β receptor (LT-
βR−/−) have defects in lymphoid organ development and show disturbed archi-
tecture of the spleen (Fütterer et al., 1998; Mueller et al., 2002). Previous experi-
ments have shown that CTL responses against AdOVA were inhibited in RAG2−/−
mice despite reconstitution with splenic T cells prior to Adenovirus infection. More-
over, Plasmodium berghei infected RAG2 deficient mice did not develop ECM spe-
cific symptoms, but died around day 25 p.i. from hyperparasitemia (PhD Thesis
Beatrix Schumak). Are RAG2 deficient mice protected against ECM development
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due to devoid T and B cells or is the disturbed splenic architecture involved in
induction of neuropathology? To clarify this question RAG2−/− mice were recon-
stituted with CD8+ T cells isolated 6 dpi from WT mice. Transfer of effector T cells
reversed protection against cerebral malaria. Between day six and day eight after
PbA infection and T cell substitution RAG2−/− mice developed neurologic pathol-
ogy with 50% dying shortly after transfer of the T cells. However, RAG2−/− mice
which received T cells from naive donors did not develop cerebral malaria similar
to unreconsituted PbA infected littermates (data not shown). These experiments
demonstrate that reconstitution with naive T cells is insufficient for inducing host
immune responses and additionally suggest that priming of T cells in an intact
spleen is essential for malaria pathogenesis.
As lymphotoxin-β receptor deficient mice are known to have disturbed lymphoid
organ development (Fütterer et al., 1998) and are resistant to ECM development
(Togbe et al., 2008) we hypothesized that disrupted lymphotoxin-β signalling is
not solely responsible for ameliorated disease progression after PbA infection, but
rather disorganisation of the spleen inhibits early immune responses and thus re-
sults in changes in disease outcome. Transferring primed effector cells from in-
fected WT mice into LT-βR deficient mice and subsequent infection with PbTG led
to increased neurological deficits (figure 3.4b), 1-3 days later mice recovered but
died later of hyperparasitemia (figure 3.4a). LT-β receptor deficient mice had de-
creased parasite-specific IFN-γ responses in the spleen (figure 3.4c) and brain (fig-
ure 3.4d). Moreover, specific cytotoxicity of effector T cells was strongly reduced
(p<0.05 compared to WT mice) in knock-out mice (figure 3.4e). The absence of
Evans Blue leakage, and thus BBB disruption in LT-βR−/− mice was reduced to
the same background levels seen in naive mice (figure 3.4f) and are in line with the
observed prolonged survival and absence of neuropathology.
3.3 Antigen-presenting cells are required for the
generation ECM
Different antigen-presenting cells like dendritic cells, monocytes, macrophages and
B cells reside in the spleen and are able to take up, process and present parasite
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Figure 3.4: LT-βR−/− mice are protected against ECM and lack antigen-specific CD8+
T cells. PbTG infected WT (n=10), LT-βR−/− (n=7) or LT-βR−/−mice reconstituted at
day 0 with WT effector cells isolated from PbTG infected WT mice six dpi (n=7). Cumu-
lative survival (a) and time course of ECM development (b) was monitored. Differences
in survival were calculated with Log-rank Test (p<0.0001), ECM score is displayed as
median and range. IFN-γ concentration in supernatant of BMDC ex vivo co-culture
from naive (n=3), PbTG infected WT (n=3) and LT-βR−/− (n=4) splenocytes restimu-
lated with F8L (c) and brain lymphocytes restimulated with S8L (d), all isolated 6 dpi
when first symptoms were observed. Percent S8L specific lysis (e), Adenovirus infected
mice were included as positive control (n=2). Extravasation of Evans Blue into brain
tissue (f) was colorimetrically measured in naive (n=2), WT (n=2) and LT-βR−/− (n=4)
mice. Data are the mean and p-values below 0.05 were considered significant, calcu-
lated with ANOVA with Bonferroni post-hoc test.
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derived particles. Each cell type has distinct mechanisms, and is more or less effi-
cient in antigen-presentation and T cell stimulation. Our study aimed to elucidate
the role of different splenic APCs during priming (early), or effector (late) phase of
Plasmodium berghei infection.
3.3.1 Macrophages are involved in the generation of parasite-
specific T cell responses and ECM pathogenesis
Macrophages are the first immune-cells to encounter invading pathogens and are
very efficient in taking up whole parasites and parasite particles, but antigen pre-
sentation is dependent on prior activation and is less efficient compared to DCs. To
analyse macrophage involvement in ECM development, C57 BL/6 mice were de-
pleted of this cell type by injection of clodronate liposomes (CloLip), which induce
apoptosis after being phagocytosed. Following depletion of macrophages one day
(d-1) prior to PbTG infection, 80% of the mice survived (p<0.0002) without ECM de-
velopment, but subsequently died from hyperparasitemia. In this experiment only
10% of WT mice survived Plasmodium berghei infection (figure 3.5a). Depletion later
in the infection (d4) protected the mice to the same extent as early macrophage
depletion (data not shown). Further, lack of macrophages resulted in drastically
(p<0.01) decreased in vivo lysis of syngenic S8L labelled target cells when measured
6 dpi (figure 3.5d). Clodronate liposome administration d-1 did not only decrease
cytotoxicity of effector cells. Splenocytes and brain lymphocytes from these mice
were unable to produce IFN-γ (figure 3.5b and c, respectively). In the absence of
macrophages, MSP-1 restimulated splenocytes produced four time less IFN-γ than
WT splenocytes (p<0.001). In contrast to cytokine production in infected WT brain
lymphocytes, no IFN-γ was detected in those of naive or macrophage depleted
groups after antigen-specific restimulation. Macrophage depletion minimised BBB
disruption, as seen by notably reduced Evans Blue leakage (p<0.01 compared to
WT mice) into brain tissue (figure 3.5e).
These results support the hypothesis that macrophages are involved in detrimental
immune responses during Plasmodium berghei infection. We conclude from these
data that generation of parasite-specific responses depend on the presence of these
phagocytic antigen-presenting cells.
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Figure 3.5: Macrophages are involved in antigen-specific responses and ECM devel-
opment. Survival (a) of PbTG infected C57 BL/6 WT (n=10), d-1 clodronate liposome
(CloLips) administered C57 BL/6 mice (n=10). Differences in survival were calculated
with Log-rank Test (p<0.0002). IFN-γ concentration in supernatant of ex vivo BMDC
co-culture with splenocytes restimulated with D10L (b) and brain lymphocytes restim-
ulated with K10L (c) of naive, PbTG infected WT and d-1 CloLip administered mice
(for all groups n=4). Percent S8L specific lysis (e), a group Adenovirus infected mice
was included as positive control (n=2). Amount Evans Blue leakage into brain tissue
(f) was colorimetrically measured in naive (n=4), WT (n=3) and d-1 CloLip (n=2) mice.
Cells were isolated 6 dpi. Data are the mean and p<0.05 was considered significant,
calculated with ANOVA and with the Bonferroni post-hoc test.
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3.3.2 B cells are involved in antigen-specific effector responses
and neuropathology
B cells are also antigen-presenting cells. They posses the unique ability to bind sol-
uble antigen with surface immune-globulin receptors. After antigens have bound
to Ig-receptors, this complex is internalized and processed. To investigate the role
of B cells during Plasmodium berghei infection, inducible B cell knock-out mice were
inoculated with parasites and survival as well as cellular responses were analysed.
Mice expressing the diphtheria toxin receptor (DTR) under the control of the CD19
promoter can be depleted of CD19+ B cells by daily administration of 40ng/g diph-
theria toxin (DTX). Survival of mice lacking B cells during early (d0-d4) or late (d4-
d7) infection with P. berghei ANKA was monitored. Early absence of B cells clearly
increased survival of PbA infected mice (p<0.0014), 80% of d0-d4 depleted mice
survived without symptoms of cerebral malaria (figure 3.6a). In contrast, late de-
pletion of B cells only delayed ECM pathology (figure 3.6b) and mice died due to
neurological complications 14 dpi. Further investigations confirmed that the pres-
ence of B cells early in infection were required for efficient effector cell priming. De-
pletion of these cells shortly after infection strongly reduced antigen-specific IFN-γ
responses in splenocytes (p<0.01) and brain lymphocytes (figure 3.6c and d). Due
to low cell numbers after brain lymphocyte isolation, measured cytokine levels af-
ter restimulation are widely scattered. These results imply that in the absence of
B cells the generation of antigen-specific immune responses during early infection
are inhibited and the ECM pathogenesis suppressed.
3.3.3 Dendritic cells are promote the generation of antigen-specific
T cells and ECM development
Dendritic cells are professional APCs, like macrophages or B cells. They stand out,
however, in their enhanced ability to prime and stimulate naïve T cells or B cells
during primary immune responses. Conditional knock-out mice, which express
the Diphtheria-Toxin-Receptor (DTR) under the control of the CD11c promoter
(Hochweller et al., 2008) were used to analyse the role of CD11c+ DCs during
Plasmodium berghei infection. Daily administration of 40ng/g Diphtheria Toxin i.p.
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Figure 3.6: Priming of parasite-specific T cell responses and ECM development are
dependent on CD19+ B cells. PbA infected C57 BL/6 WT mice (n=10) and transgenic
CD19 DTR mice, administered daily with 40ng diphtheria toxin (DTX) either from d0-
d4 (n=9) or from d4-d7 (n=9) post infection were monitored for survival (a) and ECM
development (b). The Log-rank Test (p<0.0014) was used to calculate differences in sur-
vival, ECM score is displayed as median. 6dpi naive, PbA infected WT and d0-d4 post
infection DTX administered CD19 DTR mice (for all group n=4) were sacrificed and
supernatant of BMDC co-cultured splenocytes (c) and brain lymphocytes (d) restimu-
lated with D10L and K10L respectively, was analysed for IFN-γ. Results are displayed
as mean and p-values below 0.05, calculated with ANOVA and with the Bonferroni
post-hoc test, were considered significant.
depleted all CD11c+ cells. After depletion of dendritic cells in the first 4 days af-
ter PbA infection none of the mice developed cerebral malaria (p<0.0002) whereas
100% of the WT mice were moribund (figure 3.7a). Lack of DCs resulted in di-
minished antigen-specific IFN-γ responses in splenocytes (figure 3.7b) and brain
lymphocytes (figure 3.7c). In conjunction with reduced IFN-γ production, absence
of CD11c+ cells reduced lytic activity of S8L antigen-specific T cells (figure 3.7d).
Compared to S8L specific lysis in PbTG infected WT mice, cytotoxicity in CD11c de-
pleted animals was low, similar to levels in naïve mice (WT vs. DTX d0-d4 p<0.05).
CD11c+ dendritic cells are critically involved in pathogenesis of cerebral malaria,
as seen in prolonged survival and reduced antigen specific effector responses. Re-
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duced Evans Blue leakage into the brain parenchyma of CD11c depleted mice rein-
forces previous results (figure 3.7e).
Previous results, showing that DCs are involved in malaria (deWalick et al., 2007),
are supplemented by our data, demonstrating a role of dendritic cells in generat-
ing effector cells and promoting disease. All these experiments provide evidence
that dendritic cells, macrophages and B cells are critically involved in priming of
antigen-specific T cells and ECM pathogenesis.
3.4 Toll-like receptor 9 is involved in ECM
pathogenesis and but not in effector cell generation
In recent years, evidence increased that cerebral damage in Plasmodium infection is
caused by excessive pro-inflammatory responses. Effector cells, pro-inflammatory
cytokines and chemokines are involved in neuropathology. Especially, CD8+ T
cells and IFN-γ mediate fatal destruction in affected tissue. This work provides
strong evidence that indeed cytotoxic, IFN-γ producing effector cells are engaged in
pathological processes. Macrophages, B cells and dendritic cells have been shown
to be involved in detrimental responses during Plasmodium (see section 3.3.1, 3.3.2
and 3.3.3) infection. These cells are the first cells to encounter pathogens and patho-
gen derived particles, thus early recognition and signal-transduction appears to
be essential for distinct immune responses. Toll-like receptor signalling has been
discussed to be involved in the pathogenesis of ECM. In particular the role of
TLR-9 has been debated and arguments for and against TLR-9 engagement dur-
ing malaria have been presented. Signal-cascades induced by TLR-9 ligation result
in pro-inflammatory responses. We elucidated inflammatory mechanisms in ECM
development, especially antigen-specific effector responses in dependency of TLR-
9. Plasmodium berghei infected mice with a genetic TLR-9 deficiency were monitored
for ECM development and survival. The lack of TLR-9 signalling reduced the in-
cidence of fatal neuropathology in PbA infected mice to 50% (p<0.0001), whereas
all WT mice died with obvious ECM symptoms (figure 3.8a). Although 50% of
TLR-9−/− mice did not develop cerebral malaria, splenic CD8+ T cells showed
the ability after restimulation with MSP-1 peptides to produce IFN-γ (figure 3.8b).
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Figure 3.7: Dendritic cells are involved in ECM and required for antigen-specific
responses. Cumulative survival (a) of PbA infected C57 BL/6 WT mice (n=8) and
transgenic C11c DTR mice, administered daily with 40ng diphtheria toxin (DTX) d0-
d4 (n=6). The Log-rank Test (p<0.0002) was used to calculate differences in survival.
Six days post infection naïve, PbA infected WT and d0-d4 post infection DTX admin-
istered CD11c DTR mice (for all group n=3) were sacrificed and supernatant of BMDC
co-cultured splenocytes (b) and brain lymphocytes (c) restimulated with F8L, was anal-
ysed for IFN-γ. Percent S8L specific lysis (d), a group Adenovirus-OVA d0 infected mice
was included as positive control (n=2). Evans Blue leakage into brain tissue (e) was
colorimetrically quantified in naïve (n=3), WT (n=4) and CD11c DTR dtx d0-d4 (n=3)
mice. Data are the mean and p-values below 0.05 were considered significant, tested
with ANOVA and adjusted with the Bonferroni post-hoc test.
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Figure 3.8: TLR-9 signalling is needed for ECM induction but not for antigen-specific
immune responses. Survival of PbA infected C57 BL/6 WT (n=10) and TLR-9−/−
(n=10) mice was observed. Differences in survival were calculated with the Log-rank
Test (p<0.0001). Six days post infection supernatant of a BMDC co-culture with spleno-
cytes (b) restimulated with F8L from naïve, PbA infected WT and TLR-9−/− mice (n=3
for all groups) was assessed for presence of IFN-γ. Percent cytotoxic activity against
S8L labelled target cells (c) was assessed 6 dpi in naïve (n=3), PbTG infected WT (n=4),
TLR-9−/− (n=3) and d0 Adenovirus-OVA infected WT (n=2) mice. Blood-brain barrier
disruption determined by Evans Blue leakage into brain parenchyma (d) was quanti-
fied in naïve (n=3), PbA infected WT (n=4) and TLR-9−/− (n=3) mice. Data is displayed
as mean and statistically tested with ANOVA and Bonferroni correction, p-values be-
low 0.05 were considered significant.
Secreted IFN-γ levels were slightly higher than in infected WT mice but strongly
increased compared to cytokine concentrations in restimulated naïve splenocytes
(p<0.01). Moreover, no reduction in antigen-specific cyotoxicity of splenic T cells
could be observed in the absence of TLR-9 (figure 3.8c). Although, generation and
stimulation of antigen-specific effector T cells was not inhibited in TLR-9−/− mice,
blood brain barrier damage was reduced to observed background levels seen in
43
3 Results
naïve mice. In the absence of TLR-9 Evans Blue leakage (figure 3.8d), indicating
BBB disruption was reduced (compared to WT mice p<0.05). Accumulation of the
dye in brain tissue of naïve and TLR-9−/− mice was five times lower compared to
concentrations of Evans Blue in WT mice. Altogether, these results demonstrate an
involvement of TLR-9 signalling in ECM development. Moreover, our data sug-
gest that parasite-specific T cell generation in the spleen is independent of TLR-9
signalling. Nonetheless, reduced Evans Blue leakage and an intact BBB support
survival data showing increased survival and reduced neuropathology in TLR-9
deficient mice.
3.5 Plasmodium induced cerebral malaria is dependent
on Interleukin-12 and Interleukin-12 signalling
The presence of DCs as well as functional TLR-9 responses are critically involved
in the process of ECM development. Ligation of TLR-9 with its ligand results in
the production of IL-12, which in turn has the ability to stimulate CD4+ T helper
cells as well as NK cells and is known to be a potent inducer of IFN-γ . There-
fore the downstream mechanism of TLR-9 signalling, especially the role of IL-12 in
generation of parasite specific responses were analysed. IL-12 deficient mice were
infected with PbA and survival was monitored. Around 40% of IL-12p35−/−, 60%
of IL-12p40−/− and 100% IL-12Rβ1−/− PbA infected mice were protected against
ECM development (p<0.0001), while none of the WT mice survived PbA infection
(figure 3.9a). An involvement of IL-23p19, a cytokine belonging to the IL-12 super-
family and sharing the IL-12p40 subunit, could be excluded as IL-23p19 knock-out
mice died of cerebral malaria around the same time as infected WT mice. Parasite-
specific responses 6 dpi were measured in an ex vivo co-culture, and splenocytes
were restimulated for 24h with F8L. Then IFN-γ concentration in supernatant was
quantified by ELISA. Antigen-specific IFNγ response in IL-12p35 deficient mice
was notably reduced (p<0.001 compared to WT mice) reaching concentrations al-
most as low as in restimulated splenocytes from naïve donors (figure 3.9b). Fur-
thermore, lysis of target cells labelled with parasite-specific antigens was decreased
in the absence of IL-12p35 (figure 3.9c). On average, MSP-1 specific cytotoxicity in
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Figure 3.9: Development of parasite-specific T cell responses and ECM are depen-
dent on functional IL-12 and IL-12 signalling. C57 BL/6 WT (n=10), IL-p35−/−
(n=12), IL-12p40−/− (n=10), IL-12p19−/− (n=12) all on BL/6 background and IL-
12Rβ1−/− (n=5) on SV129 background were infected with PbTG and monitored for
survival (a). Differences in survival were calculated with Log-rank Test (WT vs. IL-
12p35−/− p<0.0001, WT vs. IL-12p40−/−p<0.0001, WT vs. IL-12Rβ1−/− p<0.0005)
IFN-γ concentration in supernatant of ex vivo BMDC co-culture with splenocytes from
naïve, PbTG WT and IL-12p35−/− mice (n=3) for all groups) restimulated with F8L
(b). Percent MSP-1 specific lysis (c). Extravasation of Evans Blue into the brain (d)
was colorimetrically analysed in naïve (n=3), WT (n=2) and IL-12p35−/− (n=6) mice.
Splenocytes were isolated 6 dpi from naïve, PbA infected WT and IL-12Rβ1−/− mice
(n=3 for all groups) and restimulated on BMDCs with F8L (e). S8L specific target cell
lysis (f) was analysed in naïve (n=3), PbTG infected WT (n=4) and IL-12Rβ1−/− mice.
Adenovirus-OVA infected mice (n=2) were used as positive control. Data are the mean
and p-values below 0.05 were considered significant, calculated with ANOVA and with
the Bonferroni post-hoc test.
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IL-12p35−/− mice was 9% , whereas cyotoxic effector cells in WT mice lysed 26% of
the target cells (p=0.192). Despite reduced antigen-specific IFN-γ production and
cytotoxicity, leakage of Evans Blue into brain parenchyma was not changed in IL-
12p35−/− compared to WT mice (figure 3.9d). All analysed Plasmodium berghei
infected mice showed signs of cerebral malaria (data not shown). Intact IL-12
signalling during P. berghei infection is of great relevance during ECM develop-
ment. In the absence of a functional IL-12-receptor (formed by IL-12Rβ1 and IL-12-
Rβ2), mice did not die of specific neuropathology. Moreover, almost no antigen-
specific IFN-γ production after restimulation could be detected in IL-12Rβ1−/−
(p<0.05), and IFN-γ concentrations were comparable to those of naïve mice (fig-
ure 3.9e). Antigen-specific lysis of target cells was decreased compared to WT mice
(figure 3.9f), however, this difference was not significant. Altogether these results
suggest that IL-12 and IL-12 signalling influences adaptive immune responses di-
rected against the Plasmodium parasite leading to fatal complications.
3.6 CD4+ T cells have a vital role in generating
parasite-specific responses and subsequent
ECM induction
As reviewed by Renia et al. (2006), CD8+ T cells have been shown to be the predom-
inant cell type involved in the pathogenesis of cerebral malaria . The principal role
of antigen-specific effector T cells and their dependency on APCs could be shown
in our study, extending current knowledge. Nonetheless, CD8+ T cell responses
and APC activity are also dependant on CD4+ T helper cells. Inhibition of ECM
pathogenesis after early CD4+ T cell depletion has been described previously (Bel-
noue et al., 2002 and Yañez et al., 1999). To further analyse the role of T helper
cells in parasite-specific inflammatory responses, we depleted CD4+ T cells with
neutralising antibodies, either early (1 dpi) or late (4 dpi) in infection.
40% of the mice depleted of CD4+ T cells 5 dpi survived without neuropatholog-
ical symptoms compared to 10% survival in Plasmodium berghei infected WT mice
(figure 3.10a). Differences in survival were subtle (p=0.0607), but a trend could
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Figure 3.10: CD4+ T cell responses are required for antigen-specific effector cell gen-
eration and ECM development
PbA infected C57 BL/6 WT mice (n=10) and WT mice administered 5 dpi with CD4
neutralizing antibodies (n=7) were monitored for survival (a) and ECM development
(b). The Log-rank Test was used to calculate differences in survival, ECM score is dis-
played as median. Six days post infection naïve, PbA infected WT and WT adminis-
tered with CD4 antibodies either 1 dpi or 5 dpi (for all group n=4) were sacrificed and
BMDC co-culture with splenocytes (c) and brain lymphocytes (d) restimulated with
F8L and K10L respectively, was analysed for IFN-γ in the supernatant. Results are dis-
played as mean and p<0.05, calculated with ANOVA and with the Bonferroni post-hoc
test, was considered significant.
be seen. Specific neurological symptoms were observed in depleted animals to a
similar extent as in WT mice (figure 3.10b). Further, the relevance of CD4+ T cells
for antigen-specific T cell priming was examined. Splenocytes and brain lympho-
cytes were isolated from naïve, PbA infected WT, αCD4 +d1 and αCD4 d5 adminis-
tered animals and restimulated with MSP-1- or OVA-specific peptides. Depletion of
CD4+ T cells resulted in drastically decreased IFN-γ production after restimulation
with F8L (figure 3.10c). Cytokine levels after early depletion were comparable to
those of naïve splenocytes. Late neutralization, however, did not decrease antigen-
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specific responses and IFN-γ concentrations in splenic lymphocytes and were simi-
lar to concentrations of infected WT mice. A similar cytokine pattern could be seen
in K10L restimulated brain lymphocytes (figure 3.10d). After early neutralisation
of CD4+ T cells, INF-γ responses were absent. Despite disease progression in late
α-CD4 administered mice effector responses in the brain remained at background
levels of naïve mice. Taken together, these results provide strong evidence that early
CD4 help is critically required for priming and activation of antigen-specific T cell
responses during malaria. Later in infection, CD4+ T helper cells had little involve-
ment, ECM pathogenesis and already primed effector cells cannot be inhibited by
α-CD4 treatment.
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Parasitic infections are a major health threat in developing countries. Malaria,
caused by Plasmodium spp., is one of the leading infectious disease with high lethal-
ity. Despite extensive research, mechanisms of disease development and protec-
tive or detrimental immune responses during Plasmodium infection are not fully
understood. In the last years, however, evidence has increased that malaria is an
immune-mediated disease, in particular excessive pro-inflammatory host immune
reactions might be responsible for severe disease (van der Heyde et al., 2006; Clark
and Alleva, 2009; Milner, 2010). Using a mouse model of P. berghei-induced cerebral
malaria parasite-specific responses in spleen and brain were analysed. Immunolog-
ical processes, e.g. in vivo cytotoxicity, antigen-specific IFN-γ production and blood
brain barrier (BBB) disruption in P. berghei infected mice, were examined 6 dpi. It is
known that immune-mediated damage in the brain linked to ECM pathology can
be detected five to six days after inoculation, whereas it is unknown where prim-
ing and generation of immune responses take place. Although many cellular and
molecular factors involved in cerebral malaria pathogenesis have been identified,
the organ where cellular immune responses against the parasite are generated re-
mains to be elucidated.
The aim of this thesis was to investigate the engagement of the spleen, and cellular
interactions within this organ in the development of Plasmodium berghei-induced
cerebral malaria. Another focus of this study was the detection and analysis of
parasite-specific T cell responses involved in pathogenesis. Results acquired in this
study point out the pivotal role of an intact splenic architecture and cell-cell inter-
action in the spleen in generating parasite-specific immune responses. The unique
internal structure of the spleen allows the interaction of antigen-presenting cells
with effector T cells leading to potent immune responses. Presentation of para-
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site antigen by APCs as well as TLR-9 signalling and cytokine environment have
the potential to efficiently generate effector T cells, with pathogenic capacity. This
study demonstrates that experimental depletion of DCs, macrophages, B cells, cy-
tokines or the removal of the whole splenic compartment prevents the generation of
antigen-specific effector T cells resulting in reduced pathogenicity and ameliorated
disease development.
4.1 Mouse Model of cerebral malaria
Mechanisms involved in the detrimental disease progression of cerebral malaria are
far from being completely understood. Insight into the complexity of immune reac-
tions in human cerebral malaria is limited to post-mortem and in vitro studies. Plas-
modium berghei ANKA infected C57 BL/6 mice represent a widely used and well
established animal model displaying similar features of human cerebral malaria.
Albeit similarity, plausibility of this murine model of ECM is debated (White et al.,
2010; Riley et al., 2010). Some hallmarks of human cerebral malaria, e.g. sequestra-
tion of iRBCs to endothelium, low parasite burden or vascular obstruction, are less
pronounced or absent in the murine model (White et al., 2010). Nevertheless, trans-
lation of results from murine to human studies provide the only option for detailed
observation of Plasmodium infection and pathology. Cerebral malaria is a complex
sequence of distinct interactions between host and parasite, and human studies are
limited to descriptive or correlative assertions. In the murine model of cerebral
malaria, information on immunological and parasitological events during patho-
genesis can be dissected. Although, mouse models do not correlate completely
with human malaria, yet they reveal valuable directions in malaria research, some
with great importance to mankind (de Souza et al., 2010).
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4.2 Detection of antigen-specific pathogenic T cells and
the correlation with cerebral malaria pathogenesis
Pathogenesis of cerebral malaria has been strongly linked to pro-inflammatory re-
actions and pathogenic T cells leading to accidental immune-mediated damage of
the host, over the course of infection (Belnoue et al., 2002; Nitcheu et al., 2003; Hunt
and Grau, 2003; Renia et al., 2006).
We hypothesized that priming of parasite-specific T cells is one of the essential
steps in immunopathogenesis of cerebral malaria. The importance of T cells has
been investigated extensively, however, only a few reports on parasite-specific im-
mune responses and their involvement in ECM have been published. Genetically
altered parasites expressing the model antigen ovalbumin (OVA) can be used to
detect antigen-specific immunity (Miyakoda et al., 2008 and Lundie et al., 2008).
For the first time we were able to detect cytotoxic T cells that specifically lysed
target cells labelled with the OVA peptide S8L after PbTG infection. More impor-
tant, however, with this experimental set-up we could determine that Plasmodium
berghei MSP-1 specific cytotoxic T cells were active after PbA infection. Addition-
ally, effector function of CD8+ T cells in the spleen and brain could be detected after
restimulation with MSP-1 peptides. Therefore, our study is the first demonstrating
the presence and the activity of parasite-specific (MSP-1) effector T cells in splenic
and brain tissues during Plasmodium infection. Activity and effector function of T
cells was evaluated in an indirect assay in which isolated cells were restimulated
with distinct parasite peptides and IFN-γ production was quantified with ELISA
since the numbers of isolated brain lymphocytes was too low for intracellular FACS
analysis. The transgenic OVA-expressing strain PbTG, kindly provided by Rachel
Lundie (Lundie et al., 2008), as well as Plasmodium berghei ANKA were used to
analyse antigen-specific immune responses in the spleen and brain. Apart from the
OVA class I peptide S8L, MHC class I peptides derived from MSP-1 were used to
examine antigen-specific responses during malaria. These peptides were chosen on
the basis of their peptide sequence in order to be presented by MHC-class I and are
thus, hypothetically, only able to stimulate CD8+ T cells.
Six days post infection with Plasmodium berghei, S8L-specific CTLs were present and
active in the spleen (figure 3.2a). Moreover, we were able to detect increased MSP-
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1-specific cytotoxicity in infected mice (figure 3.2b). In later experiments MSP-1
specific lysis was less pronounced in infected animals, alterations might have been
caused by differences in peptide binding to target cells. Moreover minor varia-
tions between infections and subsequent effector cell generation cannot be ruled
out. Apart from cytotoxicity, cells from infected animals produced IFN-γ in an
antigen-specific manner (figure 3.1). BBB disruption and strong increases of IFN-γ
producing cytotoxic cells in affected tissue in ECM positive mice strongly suggest
a relationship between neuropathology and effector T cells. This hypothesis is sup-
ported by results provided by Nitcheu et al. (2003), who showed that tissue damage
in the brain is dependent on the presence of activated cytotoxic T cells, as lym-
phocyte deficient ECM resistant RAG2−/− mice reconstituted with primed effector
T cells showed neuropathology. These results are in line with previous studies
demonstrating that brain infiltrating perforin+ cytotoxic T lymphocytes (Nitcheu
et al., 2003) and activated antigen-specific T cells (Miyakoda et al., 2008; Lundie
et al., 2008) are responsible for P. berghei induced neuropathology. It was shown
that the onset of cerebral malaria is dependent on T cell migration from the spleen
to the brain by chemokine promoted recruitment (Nie et al., 2009; Miu et al., 2008)
and T cell adhesion via ICAM-1 (Favre et al., 1999; Bauer et al., 2002). Taking these
results into account it is well conceivable that cerebral malaria is a directed process
rather than an uncontrolled overreaction.
Interferon-γ is a key cytokine mediating disease progression during cerebral malaria
in mice (de Kossodo and Grau, 1993; Rudin et al., 1997). However, exact mecha-
nisms involved in pathology are still being investigated and the relevance of IFN-γ
in human cerebral malaria is debated (reviewed in McCall and Sauerwein (2010)).
Although, not the classical type of antigen-presenting cells, IFN-γ activated en-
dothelial cells possess the ability to take up antigens (Geppert and Lipsky, 1985)
and present peptides via MHC class I to effector T cells leading to BBB damage
(Galea et al., 2007). The role of IFN-γ during Plasmodium infection, however, could
be double-edged. During P. chabaudi chabaudi and P. yoelii infection IFN-γ seems to
have protective properties by activating macrophages, which in turn increase par-
asite clearance (Meding et al., 1990). Interferon-γ secreted mainly by T cells, NK
cells, APCs and NKT cells has the strong ability to suppress growth of intra- and
extracellular protozoan parasites like Toxoplasma (Suzuki et al., 1988), Leishmania
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(Heinzel et al., 1991) and Trypansoma cruzi (Reed, 1988) and possesses protective
properties in animal models of the named infections.
This is the first report about endogenous Plasmodium-specific effector responses of
T cells and results add evidence that IFN-γ producing cytotoxic T cells are directly
involved in cerebral malaria pathogenesis (figure 3.1 and 3.2).
4.3 ECM development is dependent on an intact
splenic architecture and a functional interaction
between APCs and effector T cells
Plasmodium infected erythrocytes, free parasites and parasite particles are trans-
ported to the spleen with the bloodstream (reviewed in Engwerda et al. (2005)).
In the spleen, different professional antigen-presenting cells may take up, process
and present malaria antigens. Several studies suggest that T cell priming after Plas-
modium infection takes place in the spleen (Hermsen et al., 1998; Eling, 1980), but
details on cellular events have been less investigated. In order to analyse the loca-
tion where immune responses against the parasite are generated, we removed or
autotransplanted the spleen prior to Plasmodium berghei infection.
Splenectomy reduced the incidence of ECM (figure 3.3a) and also impaired the
generation of antigen-specific T cells and their subsequent responses in the brain
(figure 3.3c). Autotransplantation of splenic pieces restored parasite specific IFN-
γ responses in the brain and reversed protection to neuropathology (figure 3.3b).
BBB disruption and vascular leakage were decreased in splenectomised and in au-
totransplanted mice (figure 3.3d). It has to be taken into account that the impact of
the surgical procedure and later wound healing might influence disease progres-
sion. In a model of Streptococcus pneumoniae infection, autotransplantation restored
immune responses controlling infection (Fernandes et al., 2009), whereas splenec-
tomy rendered the mice susceptible to disease progression. Although this study
shows protective effects after autotransplantation, it is in line with our data show-
ing that the spleen is indispensable for the generation of effector responses, in the
case of PbA infection with detrimental outcome. In the absence of the spleen, in
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vivo cytotoxicity and ex vivo restimulation experiments were performed with iso-
lated blood lymphocytes, but due to minimal cell numbers analysis and evaluation
of results were impossible.
The spleen is an organ with a highly organised cellular architecture. Therefore,
the question arose whether the splenic structure and ordered cellular interaction
may be indispensable for effector cell generation and disease progression. To test
this assumption, RAG2 deficient mice and LT-βR deficient mice, both resistant to
Plasmodium berghei induced ECM development (Randall et al., 2008; Nitcheu et al.,
2003), were used in our experimental set-up. Lack of functional T and B cells or
lymphotoxin (LT) signalling causes disturbed lymphoid organ development, lead-
ing to disintegrated cellular compartments (Mebius and Kraal, 2005; Ware, 2005).
Therefore, these mice were suitable to examine the involvement of the spleen ar-
chitecture during ECM. Reconstitution of RAG2 deficient mice with naïve T cells
did not decrease survival, but reconstitution with primed T cells from P. berghei in-
fected mice showed effector activity and neurologic symptoms were obvious (data
not shown and PhD Thesis Beatrix Schumak). Similar results were obtained when
LT-βR−/− mice were reconstituted with primed T cells, but in this case only weak
symptoms of CM were seen. However, the mice recovered from disease and died
later from hyperparasitemia (figure 3.4a and b). Infected LT-βR−/− mice, in corre-
lation to resistance of ECM development, have markedly decreased cytotoxic and
antigen-specific T cells (figure 3.4). Nevertheless, disrupted splenic architecture
(Fütterer et al., 1998) is not solely responsible for the absence of neuropathology
in lymphotoxin-βR−/− mice. Togbe et al. (2008) ascribed a critical role in neuro-
inflammation and lymphocyte recruitment to the brain to LT-βR expressed on en-
dothelial cells and the lack of this pro-inflammatory cytokine may have yet to be
discovered downstream effects. Thus, permeability of the blood-brain barrier may
be influenced by LT-β signalling. However, our results from RAG2 and LT-βR de-
ficient mice suggest that strict organisation of splenic compartments has a major
role during antigen-specific T cell induction. Previous investigations in human and
mice revealed that Plasmodium spp. infection changes splenic micro-architecture
and cellular composition (Stevenson and Kraal, 1989; Urban et al., 2005; Carvalho
et al., 2007; Beattie et al., 2006). Additionally, our experiments imply that changes in
the structured compartmentalisation of the spleen prior to or early during infection
may influence immune reactions.
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Effector cell generation is inhibited in the absence of an intact spleen, but priming of
T cells in the spleen requires a complex sequence of events involving activation of
antigen-presenting cells, promotion of a pro-inflammatory cytokine environment,
cell-cell and receptor interactions and signalling between cells (figure 4.2).
4.3.1 Generation of parasite specific T cells and ECM development
is macrophage dependent
Phagocytic cells such as macrophages and monocytes home to the spleen. These
cells are especially important during blood borne infections. While they remove
pathogens and damaged or infected erythrocytes, they are also able to alter the
cytokine environment and contribute to inflammatory processes during infection.
Macrophages have a distinct location in the spleen supporting the organisation and
function of the spleen as a lymphoid organ. To test our assumption that macro-
phages are relevant in immune mediated pathology of Plasmodium berghei infec-
tion, we depleted macrophages. Antigen-specific IFN-γ production and cytotox-
icity were drastically reduced when macrophages were lacking during the prim-
ing phase of Plasmodium infection. (figure 3.5b-d). The absence of antigen-specific
effector T cells after macrophage depletion minimised fatal neurological condi-
tions, seen as prolonged survival and significantly reduced Evans Blue leakage
(figure 3.5a and e). Several studies address the role of macrophages during Plas-
modium spp. infection, however, the results contradict one another. Depletion of
macrophages shortly before the onset of CM did not protect mice against fatal neu-
ropathology (Belnoue et al., 2002). This is contrary to our preliminary observa-
tions, where depletion of macrophages four days post infection increased survival
chances (data not shown). This outcome would argue for the importance of the
presence of macrophages during the priming phase. The influence of macrophages
later during infection has recently been investigated. Whole parasites and para-
site micro-particles like haemozoin or GPI (glycosylphosphatidyl-inositol) activate
macrophages inducing high levels of circulating inflammatory mediators (Couper
et al., 2010), which could possibly further contribute to immune-mediated damage
in course of Plasmodium infection.
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Macrophages are able to generate a pro-inflammatory environment in which DC
function and T cell priming is optimized, removal of this cell type terminates the
development of cerebral malaria induced by Plasmodium berghei K173 (Curfs et al.,
1993a). However Pais and Chatterjee (2005), described a close relationship between
activation of brain macrophages, so called microglia cells, and the development
of cerebral malaria. Other cells from the macrophage lineage may also have a
role in disease progression. However, we would argue that macrophages have
a decisive role in the priming phase in the spleen. This hypothesis is supported
by a recent study from Backer et al. (2010) demonstrating that marginal metal-
lophilic macrophages, residing at the interface of the marginal zone, collaborate
with dendritic cells to generate cytotoxic T cells. Together with our findings, splenic
resident macrophages, included in the network of well structured compartments
in the spleen, have a considerable role during disease development (figure 4.2).
At the present further experiments are being conducted to investigate the role of
macrophages during cerebral malaria in detail.
4.3.2 B cells are involved in priming effector T cells and
Plasmodium berghei induced neuropathogenesis
The spleen harbours not only T cells, macrophages and dendritic cells, but also B
cells. This cell type is of great importance in mounting antibody-mediated immu-
nity. B cells, as well as the other cells have a specific localisation in the spleen,
adding to a structured micro-architecture. To analyse the function of CD19+ B
cells in priming of effector responses during malaria, we used mice expressing
Diphtheria-Toxin-Receptor under the control of CD19. By injection of diphtheria
toxin (DTX) B cells expressing CD19 could be depleted. Depletion of CD19+ cells
early in PbA infection increased survival chances and reduced IFN-γ responses af-
ter antigen-specific restimulation (figure 3.6). Interestingly, the absence of CD19+
cells in a later phase of infection delayed but did not inhibit ECM development.
Neuropathology, as measured by the ECM score, increased till day 13 post infec-
tion in mice depleted of CD19+ cells from d4 till d7 post infection but not in early
depleted mice. One day later ECM positive mice succumbed to severe brain dam-
age (figure 3.6b). This study did not elucidate the role of B cells as antibody pro-
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ducer, therefore, assumptions concerning functions other than their importance in
antigen-specific T cell priming during cerebral malaria cannot be made. The in-
volvement of B cells during cerebral malaria has been excluded (Yañez et al., 1996).
However, antibody-secreting B cells have been correlated with protective immu-
nity to secondary Plasmodium infection (Nunes et al., 2009; Stephens et al., 2009).
Nevertheless, we could show that B cell deficiency resulted in abrogated T cell re-
sponses and led to prolonged survival without neurological complications. Our
findings indicate an involvement of the spleen and its functional micro-architecture
in parasite-specific effector responses causing detrimental outcome of malaria. We
ascribe similar functions as dendritic cells and macrophages to B cells, i) in sustain-
ing the splenic micro-architecture and ii) in antigen presentation and generation of
antigen-specific responses. Our hypothesis is further supported by recent findings
describing CD19+ cells (You et al., 2009) and B cells in general (Nolte et al., 2004) to
be critical to marginal zone development and maintenance. The absence or gradual
depletion of B cells led to a loss of metallophilic and marginal zone macrophages.
The relationship of B cells, DCs and macrophages determining their localisation
in splenic compartments and the generation of antigen-specific T cells and their
role during ECM pathogenesis must be further investigated. Histological examina-
tion of the spleen from ECM positive WT or APC deficient mice would have to be
analysed, providing more information on how the micro-architecture and cellular
interactions affect T cell priming.
4.3.3 Dendritic cells drive antigen specific T cell differentiation
and induce cerebral malaria
Dendritic cells provide a critical link between innate and adaptive immunity and
have the unique ability to take up antigen without prior activation, rapidly pro-
cess antigens and activate and prime naïve T cells. As we have previously shown
antigen-specific T cells are readily present in cerebral malaria positive mice, we pre-
dicted that priming of those cells might be linked to the presence of dendritic cells.
We demonstrated in this study that the early absence of DCs increased survival,
reduced antigen-specific cytotoxicity and ameliorated extravasation of Evans Blue
into brain tissue (figure 3.7). These data supplement previous results from deWal-
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ick et al. (2007) showing that conventional dendritic cells are critically required for
antigen specific responses by T helper cells (deWalick et al., 2007). Depletion of con-
ventional CD11c+ DCs, especially in the early phase of Plasmodium berghei infection
reduced T cell responses and reduced cerebral inflammation. On the one hand, DC
function is inhibited during Plasmodium infection (Millington et al., 2007) leading to
reduced T cell priming or a switch in T helper responses towards Th2 and poten-
tially limiting damaging processes (Sponaas et al., 2006). On the other hand, DCs
have been described to be critically involved in shaping protective CD4+ Th1 re-
sponses during a parasitemia model with blood stage P. chabaudi (Ing et al., 2006).
Contrasting reports on dendritic cell biology during Plasmodium infection originate
most likely from the use of different mouse and/or parasite strains. However, even
the same strain of Plasmodium (PbA) might induce slightly divergent immune re-
sponses (Amani et al., 1998).Wilson et al. (2006) discuss P. berghei induced inhibi-
tion of cross-presentation by DCs and subsequent reduction of CD8+ cell priming.
On the contrary, activation of dendritic cells by iRBC internalisation (Seixas et al.,
2009) and proliferation and activation of CD8+ effector cells driven by CD8α DCs
in an ECM model has been demonstrated (Lundie et al., 2008). Results of our study
are in line with the latter two articles, demonstrating that early presence of DCs
and potent presentation of parasite antigen to effector cells is crucially involved in
cerebral malaria development (figure 4.2).
Our experiments provide evidence that antigen-presenting cells are critically in-
volved in priming of antigen-specific T cells. In the absence of either B cells,
macrophages or dendritic cells generation of effector T cells is inhibited or reduced
and disease progression to cerebral malaria is ameliorated. The importance of the
early priming phase in the spleen, involved cells and implications for disease devel-
opment were demonstrated in our study. Involvement of APCs as effector cells in
the late phase of cerebral malaria is currently investigated in our laboratory. Taken
together, these findings indicate the spleen and its complex architecture to be of
great importance for the induction of antigen-specific responses during cerebral
malaria.
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4.4 Toll-like-receptor-9 signalling and IL-12 promote
neuropathology in Plasmodium berghei infection
Pathogen derived molecules such as unmethylated oligonucleotides, lipopolysac-
charides (LPS), GPI (glycosylphosphatidylinositol) or RNA are recognised by the
innate immune system through pattern recognition receptors (PRR). A special sub-
set of PRRs are the Toll-like receptors (TLRs), mainly expressed on cells of the innate
immune system. TLR-9, expressed by DCs, macrophages and B cells has the ability
to sense short DNA sequences and to signal via the adaptor molecule MyD88 to
induce strong pro-inflammatory responses. Based on our previous results, we hy-
pothesised that production of IFN-γ and IL-12 are at least partially a consequence
of TLR-9 signalling. Our results demonstrate that TLR-9 deficient mice survived
Plasmodium berghei infection better than WT littermates. Fewer animals developed
neurological symptoms (figure 3.8a) compared to C57 BL/6 WT mice, but ECM
negative mice died later suffering from hyperparasitemia. Interestingly, the absence
of TLR-9 did not reduce antigen-specific IFN-γ production by T cells ex vivo (fig-
ure 3.8b). Nevertheless, a drastic decrease of cytokine production in restimulated
brain cells was observed (figure 3.8c). The role of TLR-9 signalling in ECM devel-
opment has been controversially debated (Togbe et al., 2007; Lepenies et al., 2007;
Coban et al., 2007). Therefore, it is reasonable that our results reflect mechanisms
of TLR-9 involvement in immune cell priming which, up to now have, not been
considered. Signalling through the TLR-9 pathway results in pro-inflammatory
reactions including strong upregulation of type I interferons and IL-12 followed
by induction of adaptive immune responses (Wagner, 2004). Plasmodium parasites
have been shown to induce upregulation of TLR expression, essential to initiate IL-
12 and IFN-γ responses (Franklin et al., 2009). Reduced IL-12 responses in TLR-9
deficient mice might lead to reduced IFN-γ production, which in turn is involved
in ECM development. The absence of TLR-9 signalling alters adaptive immune
responses and lymphocytes, especially antigen-specific T cell migration to lungs
during Cryptococcus neoformans infection (Zhang et al., 2010). Our results show that
antigen-specific cytotoxic T cells are present in TLR-9 deficient mice despite the ab-
sence of ECM, together with the study from Zhang et al. (2010), it is conceivable that
the lack of TLR-9 inhibits migration of splenic antigen-specific effector cells to brain
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tissue, possibly leading to a reduction in IFN-γ production in the brain. Several hu-
man genetic studies have addressed the role of single nucleotide polymorphisms
in toll-like receptor genes or associated promoter regions. A SNP in the TLR-4 gene
predisposes African children to severe malaria and disease manifestation (Mocken-
haupt et al., 2006), and SNPs in TLR-9 could be correlated with increased incidence
of CM and increased serum IFN-γ (Sam-Agudu et al., 2010). Complex interaction
between APCs, effector cells and cytokines during cerebral malaria are sensitive to
changes and compensation through other mechanisms is only partially possible.
TLR-9 activation induces the production of interleukin-12 important for differenti-
ation of CD4+ T helper cells and activation of T cells and NK cells. IL-12 is a Th1
promoting cytokine, mainly produced by DCs but also by macrophages and mono-
cytes, that potently stimulates NK and T cells to produce IFN-γ. As we have shown
that macrophages as well as DCs were involved in antigen-specific T cell priming
and induction of neuro-inflammation, we wanted to analyse whether IL-12 was also
a part of this complex network. Moreover, we hypothesised that antigen-specific
IFN-γ responses, known to be crucial for ECM development, were inhibited in the
absence of IL-12. We analysed IL-12p35−/− mice and mice deficient in IL-12Rβ1
for ECM development, survival, BBB disruption and their ability to produce IFN-γ
after antigen-specific restimulation. Mice survived passed the ECM development
window when they lacked IL-12p35, IL-12p40 or IL-12Rβ1 (figure 3.9a). As the IL-
23p19 forms a heterodimer with the IL-12p40 subunit the possibility that this IL-12
related cytokine was involved in cerebral malaria needed to be excluded and found
not to be the case (figure 4.1). The regulatory cytokine IL-35, consisting of the IL-
12p35 subunit and Ebi3 protein was ruled out to be of major importance in T cell
generation and ECM development, as mice lacking the proteins IL-12p40, IL-12p35
or both had ameliorated disease progression and decreased T cell responses. In the
absence of IL-12 or IL-12 signalling, splenic T cells were unable to produce IFN-γ af-
ter stimulation with parasite peptides (figure 3.9b, e). However, protection against
Plasmodium berghei induced pathology was not complete and effector responses
incompletely abrogated in IL-12p35 deficient, suggesting that IL-12 independent
mechanisms contribute to immune damage. IL-12Rβ1 deficiency completely pro-
tected mice against ECM development and splenocytes produced no IFN-γ upon
restimulation, although specific lysis was not greatly altered. IL-12Rβ1−/− mice
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were on the 129 Sv background have the H-2kb and H-2db haplotype, also found
in C57 BL/6 mice. 129 Sv mice are described to be susceptible to P. berghei infec-
tion and develop cerebral malaria with haemorrhage and leukocyte sequestration
(Amani et al., 2000). We did not analyse Plasmodium berghei infected WT 129 Sv mice
for survival but ex vivo experiments showed increased vascular leakage of Evans
Blue into the brain parenchyma, whereas Evans Blue remained on background lev-
els in ECM-resistant IL-12Rβ1−/− mice (data not shown). Nevertheless, increased
Figure 4.1: Family of IL-12 and IL-12 receptors
survival, reduced pro-inflammatory and cytotoxic potential of splenocytes argue
for a strong involvement of IL-12 and IL-12 signalling in ECM development. Pre-
vious reports only examined the role of IL-12 during blood-stage infection with
Plasmodium chabaudi AS, a model for severe malaria anaemia. Splenic macrophage
derived IL-12p70 was increased in C57 BL/6 mice clearing P. chabaudi AS infection
and showing no fatal anaemia (Sam and Stevenson, 1999b). Moreover, expression
analysis of resistant BL/6 mice infected with P. chabaudi AS has shown that IL-
12Rβ1 and β2 mRNA was upregulated in the spleen (Sam and Stevenson, 1999a).
It has been discussed that induction of protective IFN-γ responses are critically
required for parasite clearance and required for antibody-mediated immunity (Su
and Stevenson, 2002). Besides protective properties, IL-12 has been assigned to
have pathogenic potential. Blood stage Plasmodium berghei NK65 infection is ame-
liorated after IL-12 depletion (Yoshimoto et al., 1998). In ECM resistant IFN-γR
deficient mice, reduced mRNA levels of IL-12 were observed (Rudin et al., 1997).
During human malaria, reduced levels of IL-12 have been associated with increased
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development of severe symptoms. Moreover, a polymorphism in the promoter re-
gion of the gene encoding IL-12p40 was linked to reduced IL-12p70 serum concen-
trations and correlated with a higher risk for CM development. Diverging functions
of IL-12 during malaria may be attributed to differing models and different study
designs. IFN-γ clearly has pathogenic functions during Plasmodium berghei ANKA
infection, hence it is conceivable that the IFN-γ inducing cytokine IL-12 might also
have immunopathogenic properties. However, results from human studies are con-
tradictory to those of murine models. In Plasmodium berghei infection, IL-12 and
IFN-γ expression is limited to a specific time frame in which progression to ECM is
determined (Mitchell et al., 2005; McCall et al., 2010). Cytokine kinetics and organ
specific expression patterns from human patients are lacking making it difficult to
determine the relevance and implication of the human results. Our study demon-
strates the importance of IL-12 for mediating effector cell generation and pathogen-
esis during parasite infection. In order to draw further conclusions, the source of
IL-12 and cell types that are directly activated still need to be elucidated.
In conclusion, a pro-inflammatory cytokine environment, especially IL-12 signalling
is a prerequisite in antigen-specific T cell generation. The skew to a more pro-
inflammatory response during Plasmodium infection depends on the functional TLR-
9 signalling and following changes in cytokine milieu involved in T cell priming
and activation.
4.5 CD4+T helper cells affect generation of
parasite-specific effector responses and
ECM development
CD4+ T cells, also called T helper cells, are required for shaping adaptive immu-
nity, especially CD8+ dependent responses. DCs and macrophages which have
detected pathogenic material via toll-like receptors produce high levels of IL-12.
This cytokine in turn activates CD4+ T cells which are then able to recognize anti-
gen presented in an MHC class II context. Antigen recognition and co-stimulation
through surface molecules and cytokines culminate in distinct patterns of signal
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cascades leading to initiation of most adaptive immune responses. Activation of
CD4+ T cells by IL-12 shapes differentiation towards Th1 phenotype. Activated
Th1 cells are able to produce high amounts of IFN-γ , critically required for MHC
class I upregulation and macrophage activation. Studies from Belnoue et al. (2002)
and (Yañez et al., 1996) have shown that early depletion of CD4+ decreases suscep-
tibility to cerebral malaria, depletion at a later time point at the onset of symptoms
did not inhibit disease progression. However, mice deficient in CD4+ T cells due to
genetic knock-out were protected against fatal complications from P. berghei infec-
tion. We could show that the absence of CD4+ T cells later in infection did not sub-
stantially alter ECM development and survival compared to WT mice (figure 3.10a
and b). Additionally our results suggest that the presence of CD4+ T cell help early
in infection is highly relevant for the generation of antigen-specific effector T cells
(figure 3.10c). Parasite specific IFN-γ responses in the spleen were diminished after
early depletion, whereas late depletion did not alter cytokine responses. The pres-
ence of antigen-specific responses in the spleen in mice lacking CD4+ T cells late
in infection could partially explain ECM susceptibility. Interestingly, these mice
had reduced parasite-restricted IFN-γ responses in brain cells, comparable to those
seen in early CD4+ depleted mice (figure 3.10d). Our early depletion experiments
suggest that effector T cell origin is dependent on the presence of T helper cells.
Nonetheless, when priming of effector cells is accomplished, CD4+ T cells have no
influence on effector activity. Recently ? described the interdependency of CD4+
and CD8+ T cells and parasite tissue sequestration. Together with our results this
would suggest that besides effector T cells, further mechanisms like tissue seques-
tration are responsible for ECM pathology. Although, Th1 cells are discussed to
influence parasite growth by strong induction of IFN-γ production and by acti-
vating other immune cells (Hirunpetcharat et al., 1999; Hirunpetcharat and Good,
1998), they also have a relevance in inducing pathology. Thus CD4+ T cell activity
is not solely restricted to effector T cell induction but may also influence cytokine
environment which may be independent of T cells, harmful for the BBB integrity
(Togbe et al., 2008; Randall et al., 2008). The above section clearly demonstrates
that Plasmodium induced cerebral malaria is dependent on early CD4+ T cell help,
which is a prerequisite for generation of parasite-specific responses. The absence of
IFN-γ responses in the brain of late CD4 depleted ECM-susceptible mice, however,
is not elucidated and further research is needed.
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4.6 The effector phase of cerebral malaria
According to our hypothesized model, priming of parasite-specific responses in the
spleen early in Plasmodium berghei infection is a critical step in the development of
neuropathology. We propose that ECM development can be divided into a priming
and an effector phase. As analysed in this study, priming of antigen-restricted T
cell responses requires an intact spleen architecture and is dependent on antigen-
presentation by macrophages, B cells and DCs using TLR-9 and IL-12 signalling
and CD4+ T cell help. However, this study did not, and was not intended to ad-
dress the topic of the effector phase and possible mechanisms in depth. Depletion
of dendritic cells early in infection (d0-d4 post infection) led to increased survival
and ameliorated pathology and reduced antigen-specific responses in spleen and
brain. When DCs were absent later during infection (d4-d7 post infection), mice
developed ECM symptoms and died shortly thereafter. Although disease progres-
sion was not altered in comparison to ECM-susceptible WT mice, no reduction in
cytokine production after restimulation with parasite peptides could be seen. How-
ever, antigen-specific cytotoxicity could be observed when DCs were absent late in
the infection (data not shown).
Mice administered with clodronate liposomes one day prior to infection (-d1) sur-
vived and displayed no symptoms (figure 3.5a). Although treatment with clo-
dronate liposomes 4 days post infection did increase survival chances of P. berghei
infected mice, the lack of macrophages late in infection did not inhibit genera-
tion of antigen-specific cytotoxic T cells and IFN-γ responses after restimulation of
splenocytes (data not shown, further experiments are currently being conducted).
In contrast, the early absence of macrophages reduced parasite-specific effector
functions. We hypothesize that the absence of macrophages during the priming
phase inhibits T cell generation, but that macrophages may have another role dur-
ing ECM development as seen in ameliorated pathology after clodronate liposome
administration later in the infection. Clodronate liposomes do not cross the blood-
brain barrier (Getts et al., 2008) and therefore do not eliminate brain macrophages,
which have been discussed to contribute to local CD8+ T cell responses during
cerebral pathology (Pais and Chatterjee, 2005). However, recent findings indicate
that micro-particles derived from infected erythrocytes drive macrophage activa-
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tion and contribute to systemic inflammation (Couper et al., 2010). The absence of
macrophages in the late phase of infection when micro-particle shedding and con-
centration is the highest could possibly lead to reduced overall inflammation and
decreased ECM development.
Complementary outcomes were seen in mice administered with neutralizing CD4
antibodies, where we found that survival chances and IFN-γ levels after restim-
ulation were similar to WT mice (figure 3.10). Together our results suggest that
detrimental T cell responses are generated early in infection in the spleen and are
dependent on macrophages, DCs and CD4+ T cells. Despite involvement early in
priming of effector responses, absence later in infection does not influence disease
outcome. We hypothesise that T cell priming is completed around 5 dpi and that
these cells are not, or are only partially, involved during effector phase when first
symptoms become obvious. This hypothesis is supported by several studies that
have shown that depletion of macrophages, neutrophils and CD4+ T cells in the
effector phase does not ameliorate ECM development (Belnoue et al., 2002; Chen
et al., 2000). However, their involvement was not further elucidated. Gene expres-
sion analysis of ECM-susceptible mice also adds evidence that the clinical course
of Plasmodium berghei infection can be divided into two phases. Early in disease,
changes in expression levels in the brain are only subtle, whereas drastic upreg-
ulation of genes involved in apoptotic mechanisms and inflammatory responses,
especially those regulated by IFN, were seen shortly before the onset of character-
istic symptoms (Lovegrove et al., 2007; Delahaye et al., 2007).
Our study, for the first time, provides evidence that early cellular interactions in the
spleen are responsible for detrimental disease development. Most cells involved in
the priming phase are dispensable for the effector phase when T cell priming is
completed and interventions by cell depletion are insufficient for the inhibition of
ECM. These results extend the global rationale of early mechanisms involved in P.
berghei induced cerebral pathogenesis by identifying the spleen as the lymphatic tis-
sue where immune responses are primed. The spleen is the organ in which immune
responses against the parasite are generated and outcome of disease is determined.
Interpolation from the rodent model to human infection must be analysed carefully
and with a complete understanding of what the model can and cannot tell us. The
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better the understanding of immune responses leading to fatal complications, the
greater are the possibilities to find interventions against cerebral malaria.
Figure 4.2: Proposed model of cellular interactions in the spleen during priming
phase of Plasmodium berghei infection
a) Schematic view of the splenic structure. b) model of interactions in the priming
phase of Plasmodium berghei infection 1. Phagocytic uptake of iRBCs, whole parasites
or parasite particles by macrophages and possibly by B cells. 2. Macrophages are as-
sumed to transfer processed antigen DCs 3. Parasite recognition through TLRs and
induction of IL-12. 4. Secreted IL-12 drives Th1 T cell differentiation and activation. 5.
Activated CD4+ Th1 cells recognize antigen-MHC class II complexes on DCs via TCR,
thus licensing DCs for cross-presentation and produced cytokines drive cytotoxic T cell
differentiation and macrophage activation. 6. CD8+ T cells recognize parasite antigen
presented in a MHC class I context, this leads to priming of effector cell activity. Cyto-
toxic CD8+ T cells migrate to affected tissue to exert their effector function and secrete
high levels of IFN-γ, both steps critically required in ECM development.
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5 Conclusion
The spleen is an important lymphoid organ involved in early immune responses
against invading pathogens. Our results demonstrate an involvement of the spleen
and its intact micro-architecture in the pathogenesis of cerebral malaria. Early in-
teractions between antigen-presenting cells and effector cells during Plasmodium
berghei infection is critically required for the generation and priming of pathogenic
T cells. These interactions include dendritic cells, macrophages and B cells as APCs
to present parasite antigen to T cells. Specific cell-type depletion can lead to a dis-
rupted architecture in the spleen resulting in abrogation of the cellular interactions
necessary for effector responses. In the case of Plasmodium berghei infection, prim-
ing of antigen-specific T cells in the context of an intact spleen is an essential step in
neuropathogenesis. Besides named antigen-presenting cells, recognition of parasite
particles through TLR-9 and subsequent production of the pro-inflammatory IL-12
as well as CD4 T cell help is indispensable for the generation of cytotoxicity and
antigen-specific responses that will lead to pathology. Our study emphasizes the
role of pathogenic T cells during cerebral malaria as determined by the generation
of effector responses, which are dependent on structural, cellular and molecular fac-
tors. For the first time we could associate parasite-specific T cells and their close in-
terrelationship with spleen-dependent immune responses with pathology. Detailed
insights into mechanisms of disease progression are valuable for further investiga-
tions and should be considered in future drug research and treatment strategies.
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